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PROLOGUE 
As the unity of the modern world becomes increasingly a technological rather 
than a social affair, the techniques of the arts provide the most valuable means 
of insight into the real direction of our own collective purposes.1 
Transformative innovations in medicine and their ethical 
complexities create frequent confusion and misinterpretation that 
color our imagination.  Placed in historical context, theatre provides a 
framework to reflect upon how the ethical, legal, and social 
implications of emerging technologies evolve over time and how 
attempts to control fate through medical science have shaped—and 
been shaped by—personal and professional relationships.2  The 
1  MARSHALL MCLUHAN, THE MECHANICAL BRIDE: FOLKLORE OF INDUSTRIAL MAN 87 (The 
Vanguard Press 1951). 
2  This article is part of a broader bioethical and legal research project to stimulate 
interdisciplinary discourse on the implications of emerging medical technologies and to 
enhance the health policy process.  By creating an analytical framework using theatre 
chronologically, it deepens our understanding of the ethical complexities raised by medical 
innovations in the context of society.  To illuminate these issues, excerpts from a sample of 
established and lesser known theatrical productions were selected after reading and 
analyzing hundreds of plays, attending live performances, and listening to audio recordings 
from the LA Theatre Works Relativity series.  See generally Karen Rothenberg, From Eugenics 
to the “New” Genetics: “The Play’s The Thing,” 79 FORDHAM L. REV. 407 (2010); Karen 
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drama of these human interactions is powerful and has the potential 
to generate fear, create hope, transform identity, and inspire 
empathy—a vivid source to observe the complex implications of 
translating research into clinical practice through the lens of other 
individuals.  Such images bring to life the tension and depth of 
emotions depicted in a broad spectrum of plays encompassing 
numerous medical subspecialties, including infectious disease, 
psychiatry, assisted reproduction, genetics/genomics, oncology, 
neuroscience, and regenerative medicine.  They also reflect the role 
that legal and bioethical principles can play to mediate these tensions 
in society. 
Narratives from theatrical productions spanning three 
centuries3—from Richard Peake’s 1823 Presumption; or, The Fate of 
Frankenstein4 to Sharr White’s 2011 The Other Place5—illuminate 
reactions to advancing medical technologies and interventions that 
have the potential to alter our destiny.  From a scientist’s 
presumption that he will have the power to bring to life new 
creations, to a neuroscientist’s belief that clinical drug trials will 
allow her to avoid entering the “other place” of her dementia, the 
dramatic arts offer a rich vehicle for exploring transformative 
innovations in medicine and their ethical and legal implications.6  
“Theatre, given its cast of characters, is the social art form par 
excellence. . . . it grants life to the whole consort, and asks us to see 
Rothenberg & Lynn Bush, Genes and Plays: Bringing ELSI Issues to Life, 14 GENETICS IN MED. 
274 (2012).  
3  The specific date accorded to each play is not absolute. Generally, several years elapse from 
revisions in manuscript to publication and, from small regional venues to prominent 
national theatres. In addition, revivals often occur decades or centuries later, sometimes 
with significant changes to the characters and dialogue. Although most of the plays are 
placed in their relative chronological order, a few contemporary plays are situated a few 
years before or after to better analyze the evolution of an ethical theme. Furthermore, 
placement of the plays is based upon the era in which the playwright created the theatrical 
drama, rather than the decade in which the actual event occurred. 
4  RICHARD BRINSLEY PEAKE, PRESUMPTION; OR, THE FATE OF FRANKENSTEIN (Stephen C. 
Behrendt ed., Romantic Circles) (1823), available at  http://www.rc.umd.edu/editions/ 
 peake/toc.html (last visited Jan. 25, 2012).   
5  See SHARR WHITE, THE OTHER PLACE (Dramatists Play Service 2011). 
6  PEAKE, supra note 4; WHITE, supra note 5, at 41-42. 
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just how porous, how interdependent, how infected, our private 
‘agenda’ really is.”7 
As the scientific landscape shifts at an ever increasing pace, it 
becomes even more essential to search for creative approaches to 
better understand the issues and to place them in historical and 
societal context.  With these goals in mind, this article is structured in 
the format of a play with six Acts representing the evolution of 
societal issues raised by attempts to manipulate fate by advances in 
medical science.  Excerpts from forty-six plays are integrated 
chronologically to reflect the ethical and legal context of their era—
and the analysis of the themes that reoccur over the centuries. 
The first Act, “Creatures Large & Small,” sets the stage beginning 
in the early nineteenth century and takes us to the beginning of the 
twentieth, exploring both the promises and perils of experimentation 
with emerging medical technologies.  From the debut of the creation 
of a monster in Frankenstein8 to the control of microbes in An Enemy of 
the People9 to the choice of who gets medical resources in the Doctor’s 
Dilemma,10 these and other early plays dramatize complex issues for 
our society that we continue to grapple with today.  We build on 
these ethical challenges in Act II, “Mendel, Docs & Rabbits,” within 
the context of inheritance theory in To-morrow11 and Strange 
Interlude,12 to infection control historically represented in Spirochete,13 
to insanity, capacity and consent in Harvey.14  The third Act, “Genes, 
7  ARNOLD WEINSTEIN, A SCREAM GOES THROUGH THE HOUSE: WHAT LITERATURE TEACHES US 
ABOUT LIFE 33 (2003). 
8  PEAKE, supra note 4. 
9  HENRIK IBSEN, AN ENEMY OF THE PEOPLE (1882), reprinted in FOUR MAJOR PLAYS, VOLUME II:
GHOSTS; AN ENEMY OF THE PEOPLE; THE LADY FROM THE SEA; JOHN GABRIEL BORKHAM 83 (Rolf 
Fjelde trans., Signet Classics 2d ed. 1970). 
10  GEORGE BERNARD SHAW, THE DOCTOR’S DILEMMA (1906) (Digireads 1911). 
11  PERCY MACKAYE, TO-MORROW:  A PLAY IN THREE ACTS (Frederick A. Stokes, 1912). 
12  EUGENE O’NEILL, STRANGE INTERLUDE (1927) (1928), reprinted in THREE PLAYS:  DESIRE 
UNDER THE ELMS; STRANGE INTERLUDE; MORNING BECOMES ELECTRA 65 (Vintage Books 
1995). 
13  ARNOLD SUNDGAARD, SPIROCHETE (1938), available at http://dspace.wrlc.org/doc/ 
 bitstream/2041/60699/Spirochetedisplay.pdf. 
14  MARY CHASE, HARVEY (1944) (Dramatists Play Service 1970). 
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Dreams & Screams” evolves from the discovery of the Double Helix 
in 1953 to the formalization of the discipline of bioethics and a 
heightened interest in end-of-life and neuropsychiatric disorders. 
Excerpts from such plays as Who’s Afraid of Virginia Woolf,15 Whose Life 
is It Anyway?,16 Children of A Lesser God,17 and Agnes of God18 
illuminate a diverse range of ethical and legal dilemmas from 
imagining our future with DNA to death with dignity, disability and 
deafness, and the determination of truth, respectively. 
Beginning in the 1980s, Act IV, “AIDS & Evers,” links two major 
public health epidemics that disproportionally impacted large 
numbers of vulnerable and marginalized populations.  From The 
Normal Heart,19 to Angels in America20 to Miss Evers’ Boys,21 we witness 
how society and science respond to threats of infectious diseases, 
including the AIDS epidemic and the legacy of Tuskegee where 
treatment for syphilis was withheld.  Act V, “Hi Tech, Lo Tech & No 
Tech,” explores fifteen years beginning with the initiation of mapping 
the human genome and the acceleration of emerging medical 
technologies with their ethical, legal, and social implications.  From 
chromosomes to codes to clones to no codes, a wide variety of plays 
including Twilight of the Golds,22 Wit,23 A Number24 and 33 Variations25 
bring to life the debate over the use and misuse of medical 
technology.  The final Act, “Genomes & Unknowns,” includes a 
15  EDWARD ALBEE, WHO’S AFRAID OF VIRGINIA WOOLF? (Dramatists Play Service 2004) (1962). 
16  BRIAN CLARK, WHOSE LIFE IS IT ANYWAY? (1972) (Dramatic Publishing 1974). 
17  MARK  MEDOFF, CHILDREN OF A LESSER GOD (1979) (Dramatists Play Service 1980). 
18  JOHN PIELMEIER, AGNES OF GOD (Samuel French 1982). 
19  LARRY KRAMER, The Normal Heart (1985), in THE NORMAL HEART AND THE DESTINY OF ME :
TWO PLAYS BY LARRY KRAMER 1 (Grove Press 2000). 
20  TONY KUSHNER, ANGELS IN AMERICA: A GAY FANTASIA ON NATIONAL THEMES (Theatre 
Communications Group 1995). 
21  DAVID FELDSHUH, MISS EVERS’ BOYS (Dramatists Play Service 1995). 
22  JONATHAN TOLINS, TWILIGHT OF THE GOLDS (1992) (Samuel French 1994). 
23  MARGARET EDSON, WIT (Dramatists Play Service 1999). 
24  CARYL CHURCHILL, A NUMBER (Theatre Communications Group 2002). 
25  MOISÉS KAUFMAN, 33 VARIATIONS (Dramatists Play Service 2011). 
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number of less-known plays, such as Lucy,26 Distracted,27 The Good 
Egg,28 and The Other Place,29 illuminating, in part, how the genomic 
revolution is expanding expectations for explanations and 
interventions for Autism Spectrum Disorder, Attention Deficit 
Hyperactivity Disorder, assisted reproduction, and Alzheimer’s 
disease.  Even though the power of technology continues to increase 
dramatically, raising more ethical implications, the urge to use 
medical innovations to manipulate our fate and those of others 
remains constant. 
ACT I: CREATURES LARGE & SMALL 
Richard Peake’s Presumption; or, The Fate of Frankenstein, is an 
illustrative starting point—the first theatrical adaptation of Mary 
Shelley’s prescient novel.30  The tension between the initial 
presumption that innovation in medical science is largely beneficial 
with the reality that the potential for inherent risks always exists in 
experimentation31 is articulated by Peake’s character, the physician-
scientist Frank: 
Aye, I am engaged heart and soul in the pursuit of discovery—a grand, 
unheard wonder. None but those who have experienced can conceive 
the enticement of Science; he who looks into the book of nature, finds 
26  DAMIEN ATKINS, LUCY (2009) (Playwrights Can. Press 2010). 
27  LISA LOOMER, DISTRACTED (Dramatists Play Service 2009). 
28  DOROTHY FORTENBERRY, THE GOOD EGG (2010) (Broadway Play Publishing 2011). 
29  WHITE, supra note 5. 
30  MARY SHELLEY, FRANKENSTEIN; OR, THE MODERN PROMETHEUS (Maurice Hindle ed., Penguin 
2003) (1818).  Shelley’s character, Dr. Victor Frankenstein, reflects: “Did any one indeed 
exist, except I, the creator, who would believe, unless his senses convinced him, in the 
existence of the living monument of presumption and rash ignorance which I had let loose 
upon the world?” Id. at 81.  Interestingly, although Shelley only used the word 
“presumption” once, the British playwright Peake seized upon the link between 
presumption and fate to dramatize the ethical and societal implications of creating and 
manipulating nature, including for the title of his play. 
31  See TOM L. BEAUCHAMP & JAMES F. CHILDRESS, PRINCIPLES OF BIOMEDICAL ETHICS (6th ed. 
2009); RUTH R. FADEN ET AL., A HISTORY AND THEORY OF INFORMED CONSENT (1986); Norman 
Howard-Jones, Human Experimentation in Historical and Ethical Perspectives, 16 SOC. SCI. & 
MED. 1429 (1982). 
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an inexhaustible source of novelty, of wonder, and delight.  What 
hidden treasures are contained in her mighty volume—what strange, 
undreamed-of mysteries!32 
Yet as scientists and others have witnessed at various times 
throughout history, this excitement over the promise of innovation 
has the potential to turn into disaster for individuals and society.33 
Reflecting on the monster he created, Frank questions: 
What have I accomplished?  The beauty of my dream has vanished! 
 . . . a flash breaks in upon my darkened soul, and tells me my attempt 
was impious . . . The dreadful spectre of a human form . . . so hideous 
as the wrench I have endowed with life!34 
Whereas the Hippocratic Oath35 espoused the paradigm “to do 
good or to do no harm” and Percival’s 1803 Medical Ethics36 expanded 
on professional virtues to gain public trust, theatre often dramatizes 
the potential of the disequilibrium in the power relationship between 
physician-scientists and patient-participants.37  An examination of 
this unequal and controlling relationship sets the stage for further 
drama illuminating the consequences—at times tragic—that extend 
beyond individuals to impact families, friends, professional 
colleagues and society. 
32  PEAKE, supra note 4, at act 1, sc. 1. 
33  See MARTIN S. PERNICK, A CALCULUS OF SUFFERING: PAIN, PROFESSIONALISM, AND 
ANESTHESIA IN NINETEENTH-CENTURY AMERICA 58-62 (1985); DAVID J. ROTHMAN, STRANGERS 
AT THE BEDSIDE: A HISTORY OF HOW LAW AND BIOETHICS TRANSFORMED MEDICAL DECISION 
MAKING 1-2 (1991); CLAUDE BERNARD, AN INTRODUCTION TO THE STUDY OF EXPERIMENTAL 
MEDICINE (Henry C. Greene trans., 1927).  
34  PEAKE, supra note 4, at act 1, sc. 3. 
35  HIPPOCRATES, THE CORPUS 1-2 (Conrad Fischer ed., 2008). 
36  THOMAS PERCIVAL, MEDICAL ETHICS; OR A CODE OF INSTITUTES AND PRECEPTS, ADAPTED TO 
THE PROFESSIONAL INTERESTS OF PHYSICIANS AND SURGEONS (1803).  See also Michael Davis, 
What Can We Learn by Looking at the First Code of Professional Ethics? 24 THEORETICAL MED. & 
BIOETHICS 433, 445 (2003). 
37  See OSLER’S BEDSIDE LIBRARY: GREAT WRITERS WHO INSPIRED A GREAT PHYSICIAN (Michael A. 
LaCombe & David J. Elpern eds., 2010). 
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In the 1837 play Woyzeck,38 Georg Büchner, the German author 
and professor of comparative anatomy, explores through caricature 
the abuses that may result from crossing the boundaries of a 
professional relationship in order to assert a dangerous degree of 
power and control over the fate of others.  The ethical and societal 
implications of human experimentation39 are magnified by the 
impoverished character Woyzeck being placed on an untenable three 
month protocol—a restricted diet of solely peas, as well as the daily 
return of a twenty-four hour urine collection.40  Büchner highlights 
the caution that must be taken if the main goal of research appears to 
focus largely on the benefits to the scientist when the Doctor tells 
Woyzeck, his deteriorating research subject, “I’m going to 
revolutionize science, I’m going to blow it all sky-high. Uric acid 0.1, 
ammonium hydrochlorate, hyperoxide.”41 
While on this experimental protocol, Woyzeck naively asks: 
“Doctor, have you ever caught sight of the other side of nature? 
Sometimes, when the sun’s up high in the middle of the day and it 
seems like the world is bursting into flames, this terrible voice starts 
talking to me.”42  The Doctor delights in the fact that Woyzeck has 
“the most beautiful aberratio mentalis partialis, category two, such a 
beautiful example” and questions him “Still doing everything as 
usual? . . . Eating your peas? . . . You’re an interesting case, Woyzeck, 
an interesting case.  You’ll be getting a bonus.  Keep at it.”43  
38  GEORG BÜCHNER, WOYZECK (1837) (1879), reprinted in COMPLETE PLAYS, LENZ AND OTHER 
WRITINGS 109 (John Reddick trans., Penguin Books 1993). 
39  See BERNARD, supra note 33. 
40  See William Henry, Experiments on the Urine Discharged in Diabetes Mellitus, with Remarks on 
That Disease, 2 MEDICO-CHIRURGICAL TRANSACTIONS 119, 119-22 (1811); William Henry, 
History of Discoveries Respecting the Uric Acid, in 2 MEMOIRS AND PROCEEDINGS - MANCHESTER 
LITERARY AND PHILOSOPHICAL SOCIETY 391 (1813); William Henry, Inaugural Dissertation on 
the Uric Acid, 4 EDINBURGH MED. & SURGICAL J. 114, 114-16 (1808); see generally Henry B. 
Jones, On the State in Which the Uric Acid Exists in the Urine, 27 MEDICO-CHIRURGICAL 
TRANSACTIONS 102 (1844). 
41  BÜCHNER, supra note 38, at 121. 
42  Id. at 122. 
43  Id. 
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Displaying the progress of his experiment with his colleagues in an 
amphitheatre, the Doctor proudly declares “this human specimen 
here, d’you see, for three months it has eaten nothing but peas, 
observe the effects, just feel how irregular the pulse is, here, and 
notice the eyes.”44  When Woyzeck remarks that “everything’s going 
dark,” the Doctor flippantly replies: “Cheer up, Woyzeck, just a few 
more days and it’ll all be over; examine him, gentlemen, examine 
him.”45 
With these short excerpts, Buchner exposes us to the unethical 
design and implementation of unscientific methods and concerns 
about the medical risks to a vulnerable individual—some of the 
issues that were addressed in the AMA Code of Ethics in 184746 and 
in subsequent codes and professional regulations that would 
continue to evolve.47  By the end of the play, we witness how an 
unethical human experiment destroys both Woyzeck’s physical and 
mental capacity, causing him to murder his wife and resulting in the 
tragic twist of their fates.48 
Norwegian playwright Henrik Ibsen’s Ghosts49 also explores the 
dynamics of controlling destiny within the family, albeit this time 
dramatizing a hereditable etiology.  In this context, the doctors 
crudely explain that congenital syphilis is inherited: “the sins of the 
fathers are visited upon the children.”50  The play depicts the son, 
Osvald, as having no control over his fate from the disease, since 
44  Id. at 126. 
45  Id. 
46  AM. MED. ASS’N, CODE OF ETHICS (1847). Over 125 years later, as a result of the Tuskegee 
syphilis study, Congress created the National Commission for the Protection of Human 
Subjects of Biomedical and Behavioral Research.  See infra note 289 and accompanying text. 
47  ROBERT BAKER, THE AMERICAN MEDICAL ETHICS REVOLUTION: HOW THE AMA’S CODE OF 
ETHICS HAS TRANSFORMED PHYSICIANS’ RELATIONSHIPS TO PATIENTS, PROFESSIONALS, AND 
SOCIETY 199-200 (1999); see also AM. MED. ASS’N, STATE MEDICAL LICENSURE REQUIREMENTS 
AND STATISTICS (2012). 
48  BÜCHNER, supra note 38, at 134. 
49  HENRIK IBSEN, GHOSTS (1881), reprinted in FOUR MAJOR PLAYS: GHOSTS; AND AN ENEMY OF 
THE PEOPLE; THE LADY FROM THE SEA 1 (Rolf Fjelde trans., Signet Classics 2d. 1970). 
50  IBSEN, GHOSTS, supra note 49 , at 55; see ALLAN M. BRANDT, NO MAGIC BULLET: A SOCIAL 
HISTORY OF VENEREAL DISEASE IN THE UNITED STATES SINCE 1880 (1985).  
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science had not yet discovered a cure.  Even “one of the foremost 
doctors” gave him little hope as Osvald reports to his mother: “Right 
from your birth, your whole system has been more or less worm-
eaten.  The actual expression he used was vermoulu.”51 
Osvald, however, finds a means to control his pain—and his 
ultimate fate—with the reluctant aid of his mother, Mrs. Alving, with 
whom he pleads to “give me that help.”52  When she viscerally 
responds, “I, who gave you life!” he quickly replies, “I never asked 
you for life. And what is this life you gave me? I don’t want it! . . . 
Have you no mother-love for me at all—to see me suffer this 
unbearable fear!”53  She reluctantly agrees, “if it becomes 
necessary,”54 to give him enough morphine to end his life—echoing 
the continuing ethical debate on assisted suicide.55 
Our inability to control fate to improve public health was at the 
center of the controversy in another Ibsen play, An Enemy of the 
People.56  By 1882, when the play was authored, innovation in science 
enabled us to detect bacteria, yet we did not have the chemical 
mechanisms to control this threat to society.57  Given the invisible 
nature of these microbes and no quick fix, it posed a great challenge 
51  IBSEN, GHOSTS, supra note 49, at 55 (emphasis in original).  
52  Id. at 80. 
53  Id. 
54  Id. 
55  See infra notes 320-33, 397-411, and accompanying text; KATHLEEN M. FOLEY & HERBERT 
HENDIN, THE CASE AGAINST ASSISTED SUICIDE: FOR THE RIGHT TO END-OF-LIFE CARE (2002); 
ARTHUR KLEINMAN, THE ILLNESS NARRATIVES: SUFFERING, HEALING, AND THE HUMAN 
CONDITION (1988); John Rawls et al., Assisted Suicide: The Philospher’s Brief, in PHILOSOPHY 
AND DEATH: INTRODUCTORY READINGS (Samantha Brennan & Robert J. Stainton eds., 2010); 
Timothy E. Quill, Physician-Assisted Death in the United States: Are the Existing “Last Resorts” 
Enough?, HASTINGS CENTER REP., Sept.-Oct. 2008, at 17. 
56  IBSEN,  supra note 9. 
57  See H. Charlton Bastian, The Germ-Theory of Disease: Being a Discussion of the Relation of 
Bacteria and Allied Organisms to Virulent Inflammations and Specific Contagious Fevers, 1 BRIT. 
MED. J. 469 (1875); K. Codell Carter, Koch’s Postulates in Relation to the Work of Jacob Henle and 
Edwin Klebs, 29 MED. HIST. 353 (1985); Germain Sée, The Tubercle Bacillus: Its Morphology, 
Mode of Detection; Its Life History; Its Results in the Human Organism; The Culture of the Tubercle 
Bacillus, 112 BOSTON MED. & SURGICAL J. 265 (1885); The History of the Germ Theory, 1 BRIT. 
MED. J. 312 (1888); The Germ-Theory a Century Ago, 1 BRIT. MED. J. 306 (1888). 
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for the town’s doctor to convince the politicians to take action to 
control the water supply and close the public baths, much like 
occurred a century later during the beginning of the AIDS epidemic.58 
Representing the views of his constituents, the town’s mayor 
doubts the seriousness of the problem that “no one can see” and 
believes that Dr. Stockmann is “exaggerating considerably.”59  The 
mayor further rebukes him: “A capable doctor must know the right 
steps to take—he should be able to control toxic elements, and to 
treat them if they make their presence too obvious.”60  Later on, Dr. 
Stockmann reflects upon his increasing frustration: “Damn it, science 
should be able to provide some counteragent, some kind of 
germicide. . . . But—everyone says this is all just imagination. . . . 
didn’t they brand me enemy of the people?”61 
In spite of scientific gains in physiology, pathology and organic 
chemistry during this time, many in the medical profession were 
frustrated by the lack of progress in having the tools to treat disease 
and alleviate suffering.  Without medications or other therapies yet to 
be developed, the inability to effectively ameliorate mental illness 
challenged physicians who felt they had little control to modify this 
fate.62  As dramatized in Chekhov’s 1895 play The Seagull,63 the caring 
physician Dorn was helpless at that time, just like his depressed 
58  See infra notes 242-73 and accompanying text; Scott Burris, Legal Aspects of Regulating 
Bathhouses: Cases from 1984-1995, in GAY BATHHOUSES AND PUBLIC POLICY 131 (William J. 
Woods & Diane Binson eds., 2003). See also LAWRENCE O. GOSTIN, PUBLIC HEALTH LAW: 
POWER, DUTY, RESTRAINT (2010). 
59  IBSEN, supra note 9, at 109, 121.  See also H. Donkin, Thoughts on Ignorance and Quackery, 2 
BRIT. MED. J. 577, 577-79 (1880); Editorial, Quackery in the Past, 1 BRIT. MED. J. 1250 (1911). 
60  IBSEN, supra note 9, at 121. 
61  Id. at 189-90. 
62  See G.E. Berrios, Melancholia and Depression During the 19th Century: A Conceptual History, 
153 BRIT. J. PSYCHIATRY 298 (1988); DEMOCRITUS JUNIOR, THE ANATOMY OF MELANCHOLY: 
WHAT IT IS WITH ALL THE KINDS, CAUSES, SYMPTOMES, PROGNOSTICKES & SEVERALL CURES OF 
IT 722 (4th ed. Oxford: Henry Cripps, 1632); W.F. Farquharson, On Melancholia: An Analysis 
of 730 Consecutive Cases, 40 BRIT. J. PSYCHIATRY 11 (1894); Theodore W. Fisher, Recent Progress 
in the Treatment of Mental Diseases, 101 BOSTON MED. & SURGICAL J. 655 (1879). 
63  ANTON CHEKHOV, THE SEAGULL (1895), reprinted in FIVE PLAYS: IVANOV, THE SEAGULL,
UNCLE VANYA, THREE SISTERS, THE CHERRY ORCHARD 65 (Ronald Hingley trans., Oxford 
2008). 
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patient, Constantine Treplev, in not being able to prevent 
Constantine’s suicide. 
Early on in the play, Constantine Treplev shares his anguish with 
his friend Nina: “I meanly killed that seagull this morning. I lay it at 
your feet.”64  Nina quickly responds in horror, “What’s wrong with 
you?” and after a pause he bluntly states, “I shall soon kill myself the 
same way.”65  Towards the end of the play, a shot is heard offstage 
and Irina, Constantine Treplev’s mother, is terrified.66  The doctor 
tries to conceal the truth: “Don’t worry.  A bottle must have gone off 
inside my medical bag, don’t worry.”67  Relieved, Irina remarks, “Oh 
dear, I was frightened.  . . . It made me feel quite ill.”68  Dorn then 
whispers to another friend in the room, “Get Irina out of here 
somehow.  The fact is, Constantine has shot himself.”69 
Even with many innovations in psychopharmacology and other 
technologies, we still do not have effective methods to adequately 
treat everyone with depression.  In fact, regardless of the 
subspecialty, physician-scientists continue to be pushed to develop 
approaches that create new hopes—along with new failures and new 
ethical dilemmas.70 
George Bernard Shaw’s 1906 play, The Doctor’s Dilemma,71 
dramatizes this reality.  Early in the twentieth century, there was a 
growing understanding of germ theory, its implications for attacking 
64  Id. at 87. 
65  Id. 
66  Id. at 115. 
67  Id. 
68  Id. 
69  Id. 
70  See Henry K. Beecher, Ethics and Clinical Research, 274 NEW ENG. J. MED. 1354 (1966); Charles 
W. Lidz et al., Therapeutic Misconception and the Appreciation of Risks in Clinical Trials, 58 SOC. 
SCI. & MED. 1689 (2004); George Rosen, Patterns of Health Research in the United States, 1900-
1960, 39 BULL. HIST. MED. 201 (1965); see generally ALBERT R. JONSEN, THE BIRTH OF BIOETHICS 
(1998). 
71  SHAW, supra note 10.  
14 HOUS. J. HEALTH L. & POL’Y
infection and its promise for controlling diseases72—yet there were 
also limits on who would be selected for experimental treatment.  A  
century later we continue to debate the ethics of allocating scarce 
resources.73 
As Shaw’s character, Dr. Ridgeon, reflects, “My laboratory, my 
staff, and myself are working at full pressure.  We are doing our 
utmost.  The treatment is a new one.  It takes time, means, and skill; 
and there is not enough for another case.  Our ten cases are already 
chosen cases.”74  He further laments, “I have had to consider, not only 
whether the man could be saved, but whether he was worth saving. 
There were fifty cases to choose from; and forty had to be condemned 
to death.”75  When a woman begs him to include her sick husband for 
Ridgeon’s “experimental test,” the doctor replies, “You are asking me 
to kill another man for his sake; for as surely as I undertake another 
case, I shall have to hand back one of the old ones to the ordinary 
treatment . . . It’s a dilemma.”76 
ACT II: MENDEL, DOCS & RABBITS 
The attempt to control the fate of others and the quest for a better 
human species, further played out through a growing fascination 
with the re-emergence of Gregor Mendel’s inheritance theory.77  
72  See generally NANCY TOMES, THE GOSPEL OF GERMS: MEN, WOMEN, AND THE MICROBE IN 
AMERICAN LIFE (1998). 
73  See RENÉE C. FOX & JUDITH P. SWAZEY, THE COURAGE TO FAIL: A SOCIAL VIEW OF ORGAN 
TRANSPLANTS AND DIALYSIS (new ed. 2002); Dyce Duckworth, Observations on Rational 
Empiricism and Scientific Medicine: The Boundaries Dividing Them, 1 BRIT. MED. J. 1217 (1911); 
K. Rakszawski & J.E. Bekelman, Allocation of High Demand, Scarce Medical Technology: Lessons 
for Proton Radiotherapy, 27 J. CLINICAL ONCOLOGY (SUPPLEMENT) e17570 (2009); Philip M. 
Rosoff, Unpredictable Drug Shortages: An Ethical Framework for Short-Term Rationing in 
Hospitals, 12 AM. J. BIOETHICS 1 (2012); Emily A. Largent & Steven D. Pearson, Which Orphans 
Will Find a Home? The Rule of Rescue in Resource Allocation for Rare Diseases, HASTINGS CENTER 
REP., Jan.-Feb. 2012, at 27. 
74  SHAW, supra note 10, at 28. 
75  Id.  
76  Id. at 30, 44.  
77  See Rothenberg, supra note 2, at 409.  See also DANIEL J. KEVLES, IN THE NAME OF EUGENICS:
GENETICS AND THE USES OF HUMAN HEREDITY (1985); WENDY KLINE, BUILDING A BETTER RACE 
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Seized upon by American playwrights, Percy MacKaye in his 1912 
play To-morrow78 promotes eugenics as unquestionable science and 
creates the character Professor Raeburn who authoritatively declares, 
“[W]e have the key which may unlock a vast kingdom of human 
happiness, the law of Mendel.”79  Based on this theory, the father in 
the play encourages his daughter to marry a “eugenically superior” 
individual rather than the man she loved whose bloodline they 
deemed tainted by congenital blindness.80  As Raeburn exclaims, 
“Sound Americans” should be bred “as carefully . . .  as their sheep 
and cattle . . . forbidding the production of the worse stock, and by 
encouraging the production of the best.”81  In fact, over the next 
decade, forced sterilization laws and restrictive U.S. immigration 
quotas were justified as social policy in part based on Mendel’s 
theory and the scientific belief in the “genetic inferiority” of 
marginalized populations.82 
Whereas Professor Raeburn believes that selective breeding is 
key to promoting strong citizens and weeding out the ill and less 
able, Dr. Knock, the titular character in Jules Romains’ 1923 French 
satire,83 is able to use propaganda to convince the townspeople that 
they are all sick—with the presumption that their fate could be 
altered by the “miracle of science.”84  In response to the rich 
hypochondriac “Lady in Purple” complaining of headaches, Dr. 
Knock inquires, “Can you picture a crab or a squid or a giant spider 
nibbling or sucking or pecking away at your brain?”85  “I suppose it’s 
(2001). 
78  MACKAYE, supra note 11.  See TAMSEN WOLFF, MENDEL’S THEATRE: HEREDITY, EUGENICS, AND 
EARLY TWENTIETH-CENTURY AMERICAN DRAMA (2009) (exploring link between American 
theatre and the eugenics movement; specifically 60, 124-25 for discussion of To-Morrow).  
79 MACKAYE, supra note 11, at 23.  
80  Id. at 22. 
81  Id. at 22-23. 
82  See Buck v. Bell, 274 U.S. 200 (1927). See also Rothenberg, supra note 2, at 413-14, 416-18. 
83  JULES ROMAINS, KNOCK (1923) (James Gidney trans., Baron’s Educational Series 1962). 
84  Jack Godin, Introduction to JULES ROMAINS, KNOCK i, vi (James Gidney trans., Baron’s 
Educational Series 1962). 
85  ROMAINS, supra note 83, at 44. 
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fatal and absolutely incurable?” she queries, then adds in 
puzzlement, “the pipe-stem thing or the spider?”86  Dr. Knock 
responds, “You can be cured of either.  I might not dare offer any 
hope to an ordinary patient who wouldn’t have either the time or the 
means for the most up-to-date methods. . . . to stick to it for two or 
three years. . . . It involves minute calculations of the dosage of 
radioactivity—and almost daily visits.”87  Like the physician in 
Woyzeck, Dr. Knock illuminates the risks that quackery presents to 
harm the health of individuals,88 as well as the potential to tarnish the 
reputation and public trust of the medical profession.89 
The unethical behavior of the physician-scientist continued to be 
examined a few years later in Strange Interlude,90 the 1928 Pulitzer 
Prize-winning play.  Eugene O’Neill uses a friendship between 
Darrell, a physician, and a married couple, Nina and Sam, to explore 
various ways the doctor could help to control the genetic fate of 
mental illness in the family.91  Darrell learns from Nina that “Sam’s 
mother told me I couldn’t have my baby.  You see, Doctor, Sam’s 
great-grandfather was insane, and Sam’s grandmother died in an 
asylum, and Sam’s father had lost his mind for years before he died, 
and an aunt who is still alive is crazy.”92  Nina then pleads for help: “I 
need your advice—your scientific advice this time. . . . I need the 
courage of someone who could stand outside and reason it out as if 
Sam and I were no more than guinea pigs.”93 
86  Id. at 44-45.  
87  Id. at 45.  
88  See RICHARD CABOT, ADVENTURES ON THE BORDERLANDS OF ETHICS (1926); John Byers, 
Quackery -- with Special Reference to Female Complaints, 1 BRIT. MED. J. 1239 (1911); A.J. Clark, 
The Historical Aspect of Quackery, 2 BRIT. MED. J. 589 (1927); Editorial, The Borderland of 
Quackery (pts. 1 & 2), 1 BRIT. MED. J. 1548 (1902), 1 BRIT. MED. J. 1608 (1902); The New 
Quackery, 4 CAN. MED. ASS’N J. 128 (1914). 
89  See Bayard Holmes, The Regulation of Quacks by Local Legislation, 20 JAMA, no. 2, 1893 at 52. 
See also Terri A. Winnick, From Quackery to “Complementary” Medicine: The American Medical 
Profession Confronts Alternative Therapies, 52 SOC. PROBS. 38, 40 (2005).  
90  O’NEILL, supra note 12. 
91  See Wolff, supra note 78, at 141-67. 
92  O’NEILL, supra note 12, at 144.  
93  Id. at 145. 
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Darrell ponders: 
Let me see. . . . I am in the laboratory and they are guinea pigs . . . in 
fact, in the interest of science, I can be for the purpose of this 
experiment, a healthy guinea pig myself and still remain an 
observer. . . .Happiness hates the timid! So does Science!  . . . and my 
duty as an experimental searcher after truth . . . to observe these three 
guinea pigs, of which I am one. . . .94 
Rationalizing his role in having sex with Nina unbeknownst to 
Sam, to help create her child, Doctor Darrell states “the man should 
have a mind that can truly understand—a scientific mind superior to 
the moral scruples that cause so much human blundering and 
unhappiness.”95 
As the play evolves, the physician friend Darrell attempts to 
justify his unethical action of agreeing to father Nina and Sam’s child 
to avoid the “ghost” of mental illness invading future generations.96  
Mirroring the concerns of the day as played out in theatre, that same 
year, Chauncey Leake, a well-respected physician, repudiated 
Percival’s 1803 Code of Ethics as being more about etiquette and not 
enough about moral, professional behavior.97  One can only imagine 
what Leake and his colleagues would have thought of Darrell’s 
experiment and its implications on human relationships and society. 
In 1933, another Pulitzer Prize winner, Men in White,98 by Sidney 
Kingsley, portrays the role of doctors in tempting fate, including the 
exploration of boundaries surrounding professional conduct.99  In 
this play, Dr. George Ferguson, a young resident, impregnates a 
nurse who later requires emergency surgery at the hospital where 
they both work, following a botched abortion elsewhere.  The senior 
94  Id. at 146-47.  
95  Id. at 149. 
96  See Ted R. Ellis, The Materialization of Ghosts in Strange Interlude, AM. NOTES & QUERIES, Mar. 
1981, at 110. 
97  Percival, supra note 36; Baker, supra note 47; ALBERT R. JONSEN, A SHORT HISTORY OF 
MEDICAL ETHICS 90 (2000). 
98  SIDNEY KINGSLEY, MEN IN WHITE (1933) (Covici Friede 4th prtg. 1934). 
99  Id. 
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physician, Dr. Hochberg, reflects with Ferguson on the current 
limitations and future hopes of introducing medical innovations to 
improve patient outcomes: “I tried . . . everything.  Caffeine 
intravenously. Adrenalin directly into the heart.  Useless!  That little 
blood-clot in the lung . . .  and we’re helpless.  Forty years I’ve spent 
in medicine . . . and I couldn’t help her.”100 
Frustrated, Ferguson questions the futility of their profession: 
“Then what’s the use? What good is it all? Why go on? It takes 
everything from you and when you need it most it leaves you 
helpless. We don’t know anything. . . . We’re only guessing.”101  In 
trying to persuade Ferguson not to give up, Hochberg tries to be 
positive: “But, at least our guesses today are closer than they were 
twenty years ago. And twenty years from now, they’ll be still closer. 
That’s what we’re here for. . . . there’s so much to be done.”102 
Attempting to create medical innovations in the wake of 
scientific uncertainty103 is also the theme explored in the 1938 Federal 
Theatre Project propaganda play Spirochete by Arnold Sundgaard.104 
In using this historical perspective to trace the evolution of syphilis 
and the quest for a cure from 1493 to 1937,105 Spirochete presents 
medical researchers and doctors as working to modify the fate of the 
disease, struggling with moralists over time who wanted to punish 
those they deemed not worthy of a cure.  The character Dr. Hoffman 
notes that in 1905 it is “increasingly apparent that the virus isolated 
by Dr. Siegel in 1898 is not the cause of syphilis,” leading another 
physician, “First Doctor,” to react, “There are as many causes found 
for syphilis as there are scientists to look for them.  Every time a man 
peers into his microscope these days he comes up shouting, ‘Ah, at  
100  Id. at 135. 
101  Id. at 135-36. 
102  Id. at 136. 
103  See RENÉE C. FOX, EXPERIMENT PERILOUS: PHYSICIANS AND PATIENTS FACING THE UNKNOWN 
237-39 (1959); J.P. Bull, The Historical Development of Clinical Therapeutic Trials, 10 J. CHRONIC 
DISEASES 218 (1959). 
104  SUNDGAARD, supra note 13, at 11.  
105  The infamous Tuskegee experiments, the legacy of which still haunts medical research, 
started over a half decade before the play was written. See infra notes 276-95 and 
accompanying text. 
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last I have found it!’ It’s ridiculous,” and further state “medicine is 
making a spectacle of itself with all these wild guesses.”106 
The play concludes by highlighting the travails of John, his 
pregnant wife Martha, and their child Tony blinded by John’s 
infection, in order to illustrate the moral imperative for passage of 
legislation to mandate prenatal and premarital testing for syphilis.107  
This type of public health initiative was made possible by 
innovations in medicine that created the tools for society to control 
the destiny of future generations.108  In contrast to the frustration 
expressed by “First Doctor” decades earlier, the current Doctor 
exclaims his excitement that public health interventions could indeed 
change fate: 
Even the unborn are not beyond our reach. . . . We can begin treatment 
as late as the fifth month and in ten cases out of eleven the child will be 
normal. The main thing is to test by the Kahn or the Wassermann and 
find out where this disease is lurking. . . . If he had been tested at the 
time of marriage it could have been prevented.109 
Innovation in the diagnosis and treatment of syphilis was just 
one example of the many advances in medical research during the 
late 1930s and early 1940s presumed to benefit society.  Through the 
discovery of the genetics of blood groups and phenylketonuria 
(PKU), researchers were able to better understand the mechanisms 
underlying a number of disorders, including hemophilia and 
thalassemia.110  With this newfound knowledge, the enthusiasm for 
testing began to fuel an interest in expanding public health screening 
measures across the country.111 
106  SUNDGAARD, supra note 13, at 57. 
107  See Id. at scene 4. 
108  See Abel Wolman, A Statement of the Position of the American Public Health Association with 
Reference to the National Health Bill of 1939 (S. 1620), 29 AM. J. PUB. HEALTH & NATION’S 
HEALTH 686 (1939); see also ALLAN M. BRANDT, NO MAGIC BULLET: A SOCIAL HISTORY OF 
VENEREAL DISEASE IN THE UNITED STATES SINCE 1880, at 149-50 (1985).  
109  SUNDGAARD, supra note 13, at 110. 
110  See SUSAN LINDEE, MOMENTS OF TRUTH IN GENETIC MEDICINE 30, 195, 198 (2005). 
111  Id. at 29, 195. 
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At the same time, some members of the public were becoming 
disenchanted with the medical profession, especially the AMA, and 
socialized medicine was being discussed as a viable option.112  The 
Federal Theatre Project explores these themes and their ethical 
implications—which are still being debated today113—in Oscar Saul 
and H.R. Hayes’s 1940 “Living Newspaper” propaganda play The 
Medicine Show.114  The reality that without access to care, innovations 
in medicine will be of little value and not be available to change the 
fate from disease of those in need is described by the Statistician 
character: 
You are listening to the beating of the human heart amplified five 
thousand times.  Every year in the United States that heart will stop in 
two hundred and fifty thousand bodies that need not die.  Now you 
must share the struggles of those who fight for life. . . . you are in the 
medical maze every day of your lives.  You can’t escape the figures.115 
In a later scene, Mackenzie, a pediatrician, expresses his 
frustration that although there is an effective medical intervention, a 
vaccine, there are “not enough doctors, no hospitals . . .” and with 
anger emphasizes “this boy has diphtheria. He’s not been 
inoculated.”116  In this public health context, the principle of social 
112  See, e.g., John A. Kenney, The National Health Act of 1939, 31 J. NAT’L MED. ASS’N 154 (1939); 
Beatrix Hoffman, Health Care Reform and Social Movements in the United States, 93 AM. J. PUB. 
HEALTH 75 (2003); Nicole Lurie, Health Disparities—Less Talk, More Action, 353 NEW ENG. J. 
MED. 727 (2005); Harold Maslow, The Background of the Wagner National Health Bill, 6 LAW & 
CONTEMP. PROBS. 606 (1939); Jeremy Rabkin, American Exceptionalism and the Healthcare 
Reform Debate, 35 HARV. J.L. & PUB. POL’Y 153 (2012); Saul S. Radovsky, U.S. Medical Practice 
before Medicare and Now—Differences and Consequences, 322 NEW ENG. J. MED. 263 (1990). 
113  See Ezekiel J. Emanuel & Steven D. Pearson, Physician Autonomy and Health Care Reform, 307 
JAMA 367 (2012); Charlotte Tucker, Health Reform Law to Have Its Day in Nation’s Highest 
Court Next Month, 42 NATION'S HEALTH 1 (2012); Arthur A. Daemmrich, U.S. Healthcare 
Reform: Reaction to the Patient Protection and Affordable Care Act of 2010 (Harvard Bus. Sch. 
BGIE Unit Case No. 711-103, 2011).  
114  OSCAR SAUL & H.R. HAYES, THE MEDICINE SHOW (1940) (1986) (photo. reprint 1988). 
115  Id. at 1-4, 1-8. 
116  Id. at 1-39. See also JAMES COLGROVE, STATE OF IMMUNITY : THE POLITICS OF VACCINATION IN 
TWENTIETH-CENTURY AMERICA 149-50 (2006); James Colgrove et al., HPV Vaccination 
Mandates—Lawmaking Amid Political and Scientific Controversy, 363 NEW ENG. J. MED. 785 
(2010). 
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justice, as dramatized in theatre, provides one of the rationales for 
expanding access to health care.117 
Even when patients have access to every innovation in medicine 
that money can buy, there is no guarantee that they will be cured. 
Moreover, technologies presumed to benefit individuals can raise 
their own set of vexing ethical dilemmas—particularly for those with 
neuropsychiatric disorders.118  In the 1944 classic Harvey, Mary Chase 
explores Elwood Dowd’s hallucinations with Harvey, his imaginary 
rabbit-friend, and his wealthy family’s conflict whether to legally 
commit him to a sanitarium where many therapeutic modalities are 
offered.119  Dr. Sanderson recommends “shock formula number 977,” 
opining that “Mr. Dowd will not see this rabbit any more after this 
injection. We’ve used it in hundreds of psychopathic cases.”120  
However, Dr. Chumley cautions, “This injection carries a violent 
reaction. We can’t give it to him without his consent. Will he give it?”  
Veta, Elwood’s sister, replies, “Of course he will, if I ask him,” to 
which Dr. Chumley questions, “ To give up this rabbit—I doubt it.” 
Myrtle, Veta’s daughter, quickly responds, “Don’t ask him. Just give 
it to him.”121 
The ethical implications of administering innovative treatments 
are complex, especially with interventions that can alter the essence 
of personality in patients who might be deemed to lack capacity to 
make their own decisions.122  This is illustrated following Veta’s taxi 
ride en route to the sanitarium, when the cab driver observes: 
117  See MADISON POWERS & RUTH FADEN, SOCIAL JUSTICE: THE MORAL FOUNDATIONS OF PUBLIC 
HEALTH AND HEALTH POLICY 80 (2006); Norman Daniels et al., Why Justice Is Good for Our 
Health: The Social Determinants of Health Inequalities, DAEDALUS, Fall 1999, at 215. 
118  See Victor E. Gonda, Treatment of Mental Disorders with Electrically Induced Convulsions, 2 
DISEASES NERVOUS SYS. 84 (1941); R.E. Hemphill & W. Grey Walter, The Treatment of Mental 
Disorders by Electrically Induced Convulsions, 87 BRIT. J. PSYCHIATRY 256 (1941); Harold D. 
Palmer et al., Therapy in Involutional Melancholia, 97 AM. J. PSYCHIATRY 1086 (1941); J.H. 
Quastel, Biochemistry and Mental Disorder, 220 LANCET 1417 (1932). 
119  See CHASE, supra note 14. 
120  Id. at 60. 
121  Id. at 65. 
122  See Paul S. Appelbaum & Thomas Grisso, Assessing Patients’ Capacities to Consent to 
Treatment, 319 NEW ENG. J. MED. 1635 (1988). 
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I’ve been drivin’ this route fifteen years. I’ve brought ‘em out here to 
get that stuff and drove ‘em back after they had it. It changes ‘em. . . .  
On the way out here they sit back and enjoy the ride. . . .  Sometimes 
we stop and watch the birds when there ain’t no birds and look at the 
sunsets when it’s rainin’. . . . But afterward—oh—oh.123 
Veta is now forced to consider all the risks of the injection on her 
brother and shouts: “Stop it—stop it—don’t give it to him! . . . I don’t 
want Elwood that way.”124  In this dramatic scene, Mary Chase 
illuminates the individual and societal implications of allowing 
others to manipulate125 the fate of vulnerable individuals.126 
ACT III: GENES, DREAMS & SCREAMS 
Following the Second World War, scientific advancement to 
modify disease was so rapid and expansive that the period is referred 
to as the “Golden Age” of medicine.127  Lithium and chlorpromazine 
provided for some pharmacological control of psychiatric disorders; 
infectious disease gained greater control when streptomycin, 
penicillin and polio vaccines were made available to the public.128  
There was a further surge in scientific innovations with a notable 
increase in federal funding for biomedical research.129  Cardiac 
pacemakers, electric defibrillators and cardiac catheterization altered 
the destiny of many families confronting heart disease;130 
123  CHASE, supra note 14, at 69.  
124  Id. at 69-70. See generally PAUL S. APPELBAUM ET AL., INFORMED CONSENT: LEGAL THEORY AND 
CLINICAL PRACTICE (1987); Jessica Wilen Berg et al., Constructing Competence: Formulating 
Standards of Legal Competence to Make Medical Decisions, 48 RUTGERS L. REV. 345, 353-54 
(1996). 
125  THOMAS GRISSO & PAUL S. APPELBAUM, ASSESSING COMPETENCE TO CONSENT TO TREATMENT:
A GUIDE FOR PHYSICIANS AND OTHER HEALTH PROFESSIONALS (1998). 
126  See APPELBAUM ET AL., supra note 124, at 23. 
127  See John C. Burnham, American Medicine’s Golden Age: What Happened to It?, 215 SCIENCE 
1474, 1474 (1982). 
128  See JONSEN, supra note 70. 
129  See Donald C. Swain, The Rise of a Research Empire: NIH, 1930 to 1950, 138 SCIENCE 1233, 1234 
(1962). 
130  See Richard Sutton et al., History of Electrical Therapy for the Heart, 9 EUR. HEART J. I3 (Supp. I, 
Dec. 2007. 
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Methotrexate, invented to modify the dismal fate from leukemia, 
opened the door for chemotherapy;131 and the birth control pill 
revolutionized family planning.132 
After the discovery of the Double Helix in 1953, 133 a whole new 
scientific field emerged—the “new genetics”— and was followed by 
prenatal genetic testing, assisted reproduction technologies and 
experimentation with gene therapy.134  With the promise of new 
genetic discoveries and technologies came the growing recognition of 
the potential perils for our future.135 
Although celebrated as a play about dysfunctional marital 
relationships, Edward Albee’s 1962 play Who’s Afraid of Virginia 
Woolf?136 also directly addresses society’s concerns about the threat of 
genetic manipulation and its implications for future generations.  Set 
on a college campus, George, the senior history professor, verbally 
attacks Nick, the young science professor: 
You’re the one! You’re the one’s going to make all that trouble . . .  I’m 
very mistrustful. . . . I read somewhere that science fiction is really not 
fiction at all . . . that you people are rearranging my genes, so that 
everyone will be like everyone else.  Now, I won’t have that! It would 
be a . . . shame.137 
Albee dramatizes the disharmony of their disciplines and 
generations—the historian who reflects on the past as prologue and 
the biologist who creates and manipulates the future—similar to 
tensions explored during the same time by C.P. Snow’s The Two 
131  See Vincent T. DeVita, Jr. & Edward Chu, A History of Cancer Chemotherapy, 68 CANCER 
RESEARCH 8643 (2008). 
132  See John A. McCracken, Reflections on the 50th Anniversary of the Birth Control Pill, 83 
BIOLOGY REPRODUCTION 684 (2010).  See also JONSEN, supra note 70, at 12 (summarizing the 
rapid advances in medical therapies throughout the course of the twentieth century). 
133  See J.D. Watson & F.H.C. Crick, Molecular Structure of Nucleic Acids: A Structure for 
Deoxyribose Nucleic Acid, 171 NATURE 737 (1953). 
134  See JAMES SCHWARTZ, IN PURSUIT OF THE GENE: FROM DARWIN TO DNA (2009). 
135  See JONSEN, supra note 70, at 177-82; LINDEE, supra note 110, at 57. 
136  ALBEE, supra note 15, at 33. 
137  Id. at 20. 
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Cultures and the Scientific Revolution.138 The dichotomy of their 
professional world views shapes their presumptions about the 
inherent benefits and risks of genetic manipulation.  George accuses 
Nick of trying to create “a race of scientists and mathematicians, each 
dedicated to and working for the greater glory of the super-
civilization. . . . There will be a certain . . . loss of liberty, I imagine, as 
a result of this experiment. . . . Cultures and races will eventually 
vanish. . .”139  Exasperated, Nick asks: “Are you finished?”140 
Albee brings to life many of the ethical and societal concerns we 
still face today: who controls the fate of science; to what extent will 
we tolerate the threat of scientific innovations altering relationships; 
what impact will genetic manipulation have on our individual, 
familial and cultural identities; and what presumptions do we share 
about the power of emerging technologies to control our fate? 
Kurt Vonnegut’s Fortitude,141 a 1960s satirical adaptation of 
Frankenstein, also explores the societal implications of experimenting 
with new technologies—creating vivid images that set up the tension 
between the fortitude to achieve scientific advances presumed to 
positively manipulate our destiny and the risks that threaten to take 
over our humanity.142  Dr. Frankenstein is a brilliant physician-
scientist who creates Sylvia, depicted as a head on a tripod hooked 
up to machines controlling her bodily functions with a master panel 
that he manipulates to keep her alive.143  Also in the basement 
138  C.P. SNOW, THE TWO CULTURES AND A SECOND LOOK: AN EXPANDED VERSION OF THE TWO 
CULTURES AND THE SCIENTIFIC REVOLUTION (1969).  See also Joseph J. Fins & Inmaculada de 
Melo-Martin, C.P. Snow's "Two Cultures" Fifty Years Later: An Enduring Problem with an 
Elusive Solution, 32 TECH. IN SOC’Y 1 (2010); Bruce Jennings, Enlightenment and Enchantment: 
Technology and Moral Limits, 32 TECH. IN SOC’Y 25 (2010); Stephen R. Latham, Law Between the 
Cultures: C.P. Snow's The Two Cultures and the Problem of Scientific Illiteracy in Law, 32 TECH. 
IN SOC’Y 31 (2010); David J. Skorton, Bridging the "Two Cultures" Divide in Medicine and the 
Academy, 32 TECH. IN SOC’Y 49 (2010). 
139  ALBEE, supra note 15, at 33 
140  Id. 
141  KURT VONNEGUT, Fortitude, in WAMPETERS, FOMA & GRANFALLOONS (OPINIONS) 43 (Dial 
Press 1999) (1965). 
142  See FOX, supra note 103. 
143  VONNEGUT, supra note 141, at 43. 
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laboratory is Dr. Swift, his assistant, and young Dr. Little, who is 
called in to help Sylvia with her request to terminate this experiment 
and let her die.144  Frankenstein points out: “Those are her kidneys 
over there.  That’s her liver, of course.  There you got her 
pancreas. . . .  Believe me, those are some expensive sweetbreads.”145 
Frankenstein proudly comments: “You don’t live like this on 
Blue Cross. . . .  I gave her her first major operation thirty-six years 
ago.  She’s had seventy-eight operations since then.”146  In addition to 
the financial implications of such fortitude, Vonnegut exposes us to 
the nascent debate over being kept alive by extraordinary means and 
having others take control of your fate.  Sylvia expresses concern: “I 
do wish I had somebody to talk to about death . . . ,”147 and then 
states: “I asked him yesterday what would happen if my brain 
started to go.  He was serene.  He said I wasn’t to worry my pretty 
little head about that. ‘We’ll cross that bridge when we come to it,’ he 
told me. . . .  Oh, God, the bridges I’ve crossed!”148  Vonnegut’s 
imagery mirrors with exaggeration many of the major technological 
advances in medicine making headlines around that time: human 
heart transplantation experiments and chronic hemodialysis 
technologies created the potential to extend life in unimaginable 
ways,149 and, as a result, complex bioethical issues began to emerge, 
challenging our presumptions about the benefits and risks of 
controlling fate.150 
144  Id.  
145  Id. at 43-44 
146  Id. at 44. 
147  Id. at 54.  
148  Id. at 55.  
149  See Renée C. Fox, The Medical Profession’s Changing Outlook on Hemodialysis (1950-1976), in 
ESSAYS IN MEDICAL SOCIOLOGY: JOURNEYS INTO THE FIELD 120, 122-23 (Transaction Books ed., 
1988); A Plea for a Transplant Moratorium, SCI. NEWS, Mar. 16, 1968, at 256, 256; Bd. on Med. 
of the Nat’l Acad. of Scis., Cardiac Transplantation in Man, 204 JAMA 805 (1968); Irving H. 
Page, The Ethics of Heart Transplantation: A Personal View, 207 JAMA 109, 110-12 (1969); 
Delford L. Stickel, Ethical and Moral Aspects of Transplantation, 3 MONOGRAPHS IN SURGICAL 
SCIS. 267, 269 (1966); J. Russell Elkington, Moral Problems in the Use of Borrowed Organs, 
Artificial and Transplanted, 60 ANNALS INTERNAL MED. 309, 310 (1964). 
150  See JAY KATZ ET AL., EXPERIMENTATION WITH HUMAN BEINGS: THE AUTHORITY OF THE 
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Much like we witness in Fortitude, the opening scene of Dale 
Wasserman’s 1964 play One Flew Over the Cuckoo’s Nest151 has health 
professionals at a master control panel monitoring patients, 
machines, transformers, and relays with “godlike” power.152  In this 
adaptation of Ken Kesey’s novel,153 the play brings to life how 
technology can be abused when under the control of an individual 
obsessed with manipulating power.154  After some provocative 
dialogue between inpatients at a state mental hospital and the 
infamous Nurse Ratched, she repeatedly taunts them with threats of 
ordering dangerous amounts of promising technologies as well as 
numerous types of questionable interventions.155  When one patient 
says he is going “down to the Shock Shop,” another explains: 
“Electro-Shock Therapy . . . [a] device which combines the best 
features of the sleeping pill, the electric chair and the torture rack. . . . 
Zap! Punishment and therapy in one shocking package.  Chief 
Broom, there.  He’s had two hundred treatments.”156 
Later on, when Nurse Ratched wants to further control their 
behavior, she threatens them with a “surgical procedure. . . . Quite 
simple, really.”157  When a naïve patient questions what the operation 
entails, a more seasoned patient responds, “I guess she means 
lobotomy. . . . [Y]ou might call it a sort of . . . castration of the 
INVESTIGATOR, SUBJECT, PROFESSIONS, AND STATE IN THE HUMAN EXPERIMENTATION PROCESS 
1-2 (1972); Renée C. Fox., A Sociological Perspective on Organ Transplantation and Hemodialysis, 
169 ANNALS N. Y. ACAD. SCIS. 416-17 (1970), reprinted in KATZ, supra note 150, at 708-09; 
Leon R. Kass, Caveat on Transplants, WASH. POST, Jan. 14, 1968, at B-1 col. 5, reprinted in 
KATZ, supra note 150, at 1070-71; What and When Is Death?, Editorial, 204 JAMA 539 (1968); 
Mita Giacomini, A Change of Heart and a Change of Mind? Technology and the Redefinition of 
Death in 1968, 44 SOC. SCI. & MED. 1465, 1471-74 (1997); Shana Alexander, They Decide Who 
Lives, Who Dies: Medical Miracle Puts a Moral Burden on a Small Committee, LIFE, Nov. 9, 1962, 
at 102, 104-06. 
151  DALE WASSERMAN, ONE FLEW OVER THE CUCKOO'S NEST: A PLAY IN TWO ACTS (1964) 
(Samuel French 1970). 
152  Id. at 5. 
153  KEN KESEY, ONE FLEW OVER THE CUCKOO’S NEST (17th prtg., New Am. Library 1962). 
154  See WASSERMAN, supra note 151. 
155  Id. at 59-66.  
156  Id. at 27. 
157  Id. at 65. 
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brain.”158  With the growing debate on psychosurgery159 and other 
advances in technology, informed consent and research ethics 
became more of an imperative.160  During this period the public’s 
perception of the benefits and risks of medical innovation was 
evolving—whether in a psychiatric context or over life and death 
issues—reflecting in part moral ambiguities for individuals, families, 
health professionals, and society.161 
The formalization of bioethics as a discipline intensified scrutiny 
of the interplay among science, policy, and the public.162  As medical 
interventions became technologically more complex, this new field of 
bioethics was framing a number of fundamental questions for society 
to consider: is the extension of life beneficial if the individual 
experiences diminished consciousness or pain? What is the benefit? 
What is the harm? Who should live and who should die when 
considering the allocation of scarce resources?163 Additional questions 
were raised over the next few decades, and the legal and ethical 
foundations of the “right to die” were established for both those 
patients who have capacity and those who may need others to decide 
on their behalf. 164 
158  Id. at 66.  
159  See NAT’L COMM’N FOR THE PROT. OF HUMAN SUBJECTS OF BIOMEDICAL & BEHAVIORAL 
RESEARCH, PSYCHOSURGERY: REP. AND RECOMMENDATIONS, at xv (1977); Walter Freeman & 
James W. Watts, Prefrontal Lobotomy in the Treatment of Mental Disorders, 30 S. MED. J. 23, 23, 
30 (1937). 
160  See Appelbaum & Grisso, supra note 122, at 1635, 1637; Nicholas D. Schiff et al., Deep Brain 
Stimulation, Neuroethics, and the Minimally Conscious State: Moving Beyond Proof of Principle, 66 
ARCHIVES OF NEUROLOGY 697, 700-01 (2009). 
161  See Alexander, supra note 150, at 104-27; Schiff, supra note 160, at 703; NAT’L COMM’N FOR 
THE PROT. OF HUMAN SUBJECTS OF BIOMEDICAL & BEHAVIORAL RESEARCH, supra note 159, at 7-
10. 
162  See TOM L. BEAUCHAMP & JAMES F. CHILDRESS, PRINCIPLES OF BIOMEDICAL ETHICS 8-9 (6th ed. 
2009); RUTH R. FADEN ET AL., A HISTORY AND THEORY OF INFORMED CONSENT 92, 96 (1986); 
JONSEN, supra note 70; DAVID J. ROTHMAN, STRANGERS AT THE BEDSIDE : A HISTORY OF HOW 
LAW AND BIOETHICS TRANSFORMED MEDICAL DECISION MAKING 247-62 (2d paperback ed., 
Walter de Gruyter 2003) (1991).  
163  See generally BEAUCHAMP & CHILDRESS, supra note 162. 
164  See ALAN MEISEL & KATHY CERMINARA, THE RIGHT TO DIE: THE LAW OF END-OF-LIFE 
DECISIONMAKING, §§ 2.01, 4.01-4.01[c] (3d ed. 2004 & Supp. 2005, Supp. 2006, Supp. 2009, 
Supp. 2011). 
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Brian Clark’s Whose Life is it Anyway?165 had a significant role in 
heightening public awareness on who decides how and when a 
patient may die, given the realities of the power dichotomy and 
innovations in medicine.166  The 1972 play illustrates the ethical 
conflict between healthcare professionals and Ken, their patient, who 
is initially kept alive by technology and is now questioning the 
quality of his life.167  Unable to physically control his own fate, Ken is 
at the mercy of others to enable him to die with dignity: “Go and 
convince Dr. Frankenstein that he has successfully made his monster 
and he can now let it go.”168  Shortly afterward, Ken emphasizes his 
position: 
I really have absolutely no desire at all to be the object of scientific 
virtuosity.  I have thought things over very carefully.  I do have plenty 
of time for thinking and I have decided that I do not want to go on 
living with so much effort for so little result . . . . I might even learn to 
do wonderful things, like turn the pages of a book with some miracle 
of modern science. . . .  But I don’t want to become happy by becoming 
the computer section of a complex machine. And morally, you must 
accept my decision.169 
To which Dr. Scott firmly replies: “Not according to my morals.”170 
Ken questions, “And why are yours better than mine?,” then 
answers for himself, “They’re better because you’re more powerful.  I 
am in your power.  To hell with a morality that is based on the 
proposition that might is right.”171  Later on, Ken reasons: 
165  CLARK, supra note 16. 
166  Alexander M. Capron, Foreword to JAY KATZ, THE SILENT WORLD OF DOCTOR AND PATIENT, 
at xxii-xxiii (Johns Hopkins Press ed., Johns Hopkins Univ. Press 2002) (1984).  See also 
FADEN ET AL., supra note 31, at 17; PETER G. FILENE, IN THE ARMS OF OTHERS: A CULTURAL 
HISTORY OF THE RIGHT-TO-DIE IN AMERICA xiv-xv, 8-9, 219 (1998); Charles Fried, Terminating 
Life Support: Out of the Closet!, 295 NEW ENG. J. MED. 390, 390-91 (1976). 
167  See CLARK, supra note 16. 
168  Id. at 30. 
169  Id. at 32, 39.  
170  Id. at 39. 
171  Id.  
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[E]ach man must make his own decision.  And mine is to die quietly 
and with as much dignity as I can muster and I need your help. . . . It is 
not undignified if the man wants to stay alive, but I must restate that 
the dignity starts with his choice.  Without it, it is degrading because 
technology has taken over from human will.  My Lord, if I cannot be a 
man, I do not wish to be a medical achievement.172 
In response to society’s growing concern with loss of control over 
how we live and how we die, the hospice movement173 was embraced 
as an alternative to counter the de-humanization of more and more 
technology on individuals and their relationships.174  Contrary to the 
medical community’s presumption at the time that everyone would 
welcome the availability of new technology, the public in fact began 
to question its value to extend life at all costs.175 
As highlighted a few years later in Michael Cristofer’s The 
Shadow Box,176 patients near the end of life and their families share 
their experiences living as part of a hospice community, including 
having support for the control of pain.177  Brian, one of the patients, 
reflects: 
Our dreams are beautiful, our fate is sad. . . .  You always think . . . no 
172  Id. at 43, 80. 
173  See SANDOL STODDARD, THE HOSPICE MOVEMENT: A BETTER WAY OF CARING FOR THE DYING 
(4th prtg. Stein & Day 1978); W. NOEL KEYES, BIOETHICAL AND EVOLUTIONARY APPROACHES 
TO MEDICINE AND THE LAW 873-74 (2007); Lainie Rutkow, Optional or Optimal? The Medicaid 
Hospice Benefit at Twenty, 22 J. CONTEMP. HEALTH L. & POL'Y 107, 109-10 (2005). See also 42 
U.S.C. § 1396r(b)(1)(B)(2) (2012); Medicare & Medicaid Programs: Reapproval of the 
Community Health Accreditation Program (CHAP) for Deeming Authority for Hospices, 68 
Fed. Reg. 55,616 (Sept. 26, 2003); 42 U.S.C. § 1395c (2012).   
174  See Anita J. Tarzian & Diane E. Hoffmann, A Statewide Survey Identifying Perceived Barriers to 
Hospice Use in Nursing Homes, 8 J. HOSPICE & PALLIATIVE NURSING 328, 335 (2006).  
175  See JOSEPH J. FINS, A PALLIATIVE ETHIC OF CARE:  CLINICAL WISDOM AT LIFE’S END 18-19 
(2006); PRESIDENT’S COMM’N FOR THE STUDY OF ETHICAL PROBLEMS IN MED. AND BIOMEDICAL 
AND BEHAVIORAL RESEARCH, DECIDING TO FOREGO LIFE-SUSTAINING TREATMENT: ETHICAL, 
MEDICAL, AND LEGAL ISSUES IN TREATMENT DECISIONS 15-18 (1983). 
176  MICHAEL CRISTOFER, THE SHADOW BOX (Samuel French 1977). 
177  See id.  See also Diane E. Hoffmann, Pain Management and Palliative Care in the Era of Managed 
Care:  Issues for Health Insurers, 26 J.L. MED. & ETHICS 267, 267-68 (1998) (explaining the 
problem of inadequate pain management for terminally ill patients). 
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matter what they tell you . . . you always think you have more time. 
And you don’t.  But I appreciate what you’re trying to do here, and I 
do enjoy being a guinea pig.178 
With resignation, his friend later acknowledges “he is terminal—
officially. . . . [T]here’s nothing they can do for him in the 
hospital . . . .  There’s some pain.  But it’s tolerable.  At least he makes 
it seem tolerable.  They keep shooting him full of cortisone.”179 
Another form of pain that is a challenge to control emanates from 
psychiatric illness, as explored in Equus.180  Peter Shaffer’s 1974 play 
centers on Alan, a child with severe reactive depression, and his 
psychiatrist, Dysart, who feels inadequate at not having the tools to 
change the fate of many of his young patients: “The thing is, I’m 
desperate. . . . All reined up in old language and old 
assumptions. . . .”181  Dysart is determined to help this boy by 
experimenting with any number of treatment modalities that might 
control his psychic pain and make him feel “normal” again.182  These 
ethical and medical challenges of treating children remain today, in 
part because there is not sufficient data to substantiate the most 
effective medical interventions.183 
Alan horrifically blinded six horses with a metal spike, and 
magistrate Hesther brings him to Dysart with the hope that the 
doctor could control the boy’s abnormal behavior and his future.184  
Alan suggests, “It’ll be the drug next. . . . Shove needles in people, 
178  CRISTOFER, supra note 176, at 22. 
179  Id. at 25.  
180  PETER SHAFFER, EQUUS (1974) (Scribner 2005). 
181  Id. at 10.  
182  See SHAFFER, supra note 180.  
183  See Michael G. Aman & Cristan A. Farmer, Psychotropic Medication Research in Children and 
Adolescents: Empirical Findings and Ethical Implications, 3 J. EMPIRICAL RES. ON HUM. RES. 
ETHICS: AN INT’L J. 39 (2008); Comm. on Bioethics, Am. Acad. of Pediatrics, Informed Consent, 
Parental Permission, and Assent in Pediatric Practice, 95 PEDIATRICS 314, 317 (1995), available 
at http://aappolicy.aappublications.org/cgi/reprint/pediatrics;95/2/314.pdf; Seema Shah 
et al., How Do Institutional Review Boards Apply the Federal Risk and Benefit Standards for 
Pediatric Research?, 291 JAMA 476 (2004).  
184  SHAFFER, supra note 180, at 12. 
KAREN H. ROTHENBERG & LYNN W. BUSH 31
pump them full of truth drug, so they can’t help saying things. 
That’s next, isn’t it?”185  Dysart discusses Alan’s request with Hesther, 
“He actually thinks they exist. . . . He wants a way to speak. . . . 
Tape’s too isolated, and hypnosis is a trick. . . . Now I am almost 
tempted to play a real trick on him . . . .  The old placebo. . . . he trusts 
me.”186  In order to reassure Dysart, Hesther observes, “The boy’s in 
pain. . . .  [a]nd you can take it away. . . . Then that has to be enough 
for you, surely?”187  Dysart cries out: 
All right! I’ll take it away!  He’ll be delivered from madness.  What 
then? . . .  Do you think feelings like his can be simply re-attached . . . ? 
My desire might be to make this boy an ardent husband—a caring 
citizen—a worshipper of abstract and unifying God.  My achievement, 
however, is more likely to make a ghost!188 
As with Equus, Bernard Pomerance’s The Elephant Man189 
explores the tension between a patient and his doctor striving for a 
trusting relationship190 to create some semblance of normalcy against 
all odds.191  Based loosely on the late nineteenth century life of John 
Merrick and his physician, Treves, The Elephant Man illustrates how a 
man with extraordinary physical deformities probably from mosaic 
proteus192—which profoundly impairs expressive communication 
and movement—is helped to thrive and survive longer than 
expected.  Treves proclaims: 
185  Id. at 78. 
186  Id. at 78-79. See also HOWARD M. SPIRO, DOCTORS, PATIENTS, AND PLACEBOS 119-20, 123-24 
(1986); Richard C. Cabot, The Use of Truth and Falsehood in Medicine: An Experimental Study, 5 
AM. MED. 344 (1903); Nancy E. Kass et al., Trust: The Fragile Foundation of Contemporary 
Biomedical Research, HASTINGS CENTER REP., Sept.-Oct. 1996, at 25, 25-27. 
187  SHAFFER, supra note 180, at 108. 
188  Id. (emphasis original) It is noteworthy how many of the plays express the image of a ghost. 
189  BERNARD POMERANCE, THE ELEPHANT MAN (Grove Press 1979). 
190  See Kass et al., supra note 186 (discussing the “fragile foundation” of trust between doctors 
and their patients). 
191  See POMERANCE, supra note 189.  
192  See Leslie G. Biesecker, The Multifaceted Challenges of Proteus Syndrome, 285 JAMA 2240 
(2001); M.J. Lindhurst et al., A Mosaic Activating Mutation in AKT1 Associated with the Proteus 
Syndrome, 365 NEW ENG. J. MED. 611, 612 (2011). 
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My aim’s to lead him to as normal a life as possible.  His terror of us all 
comes from having been held at arm’s length from society.  I am 
determined that shall end. . . .For example, he had never seen the 
inside of any normal home before. I had him to mine, and what a 
reward. . . . his astonishment, his joy at the most ordinary things.193 
While the opportunity to study such a rare disorder provides 
mutual benefits that capitalize on Merrick’s fortitude, the medical 
community’s thirst to increase their knowledge of disease processes 
fuels their fortitude to strive for the betterment of the patient.  This 
ethical paradox ultimately becomes glaring to the treating 
physician.194  Like Shaffer’s psychiatrist in Equus, and as woven 
through many plays exploring novel methods to improve outcomes 
in medicine, Treves also questions the presumption that the end is 
worthy of the means: 
As he’s achieved greater and greater normality, his condition’s edged 
him closer to the grave.  So—a parable of growing up?  To become 
more normal is to die? . . .  He—it is just a mockery of everything we 
live by. . . . I conclude that we have polished him like a mirror, and 
shout hallelujah when he reflects us to the inch.  I have grown sorry for 
it. I am in despair in fact.  Science, observation, practice, deduction . . . 
can no longer serve as consolation.195 
These internal struggles are not unusual for health care professionals 
treating individuals with chronic conditions, and the recent discipline 
of narrative medicine has evolved as a creative approach for helping 
to reflect on these emotions.196 
Whereas Merrick’s rare genetic disorder destined him to a life 
with abbreviated longevity and severe speech impediment since 
birth, Arthur Kopit’s 1978 play, Wings,197 illustrates the abrupt 
disruption of cohesive language that can result from a stroke, 
193  POMERANCE, supra note 189, at 28. 
194  See ALBERT JONSEN ET AL., CLINICAL ETHICS: A PRACTICAL APPROACH TO ETHICAL DECISIONS 
IN CLINICAL MEDICINE (7th ed. 2010). 
195  POMERANCE, supra note 189, at 64-65.  
196  See generally RITA CHARON, NARRATIVE MEDICINE: HONORING THE STORIES OF ILLNESS (2006). 
197  ARTHUR L. KOPIT, WINGS (1978) (Hill & Wang 3d prtg. 1981). 
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radically changing the course of presumed destiny in a flash.  Kopit’s 
main character, Emily Stilson, represents a composite of two actual 
women who sustained vascular insults and are being treated at a 
cutting-edge medical facility highly regarded for its stroke 
research.198  The playwright presents a striking image where forces 
combine to slowly modify the destiny of Emily’s aphasia through 
good luck and “trial and error,” even though many questions remain 
about the efficacy of these alternative approaches.199  In one of the 
scenes illustrating complementary modalities is a “deep male voice, 
speaking slowly enunciating carefully, that one hears on the speech-
therapy machine known as ‘the language master.’”200  This 
dramatization, with images of alternative and complementary 
treatments, echoes contemporary ethical and medical debates over 
how to integrate and validate new approaches to better address 
complex medical challenges.201 
In addition to the value of Emily’s fortitude, as fate would have 
it, she is left-handed, which allows for some functional retention of 
thought with left-hemisphere damage.202  And, she has a speech 
therapist, Amy, who had recovered from aphasia herself and creates 
many innovative language therapies for Emily.203  In spite of all these 
efforts, Emily is still challenged with deficits in expressive language 
functioning and inquires: “Where do you get names from? . . . Do you 
know how you do it? . . . how am I supposed . . . to learn?”204  Amy  
198  Id. at xvi. 
199  See E. Ernst, Prevalence of Use of Complementary/Alternative Medicine: A Systematic Review, 78 
BULL. WORLD HEALTH ORGANIZATION 252 (2000). 
200  KOPIT, supra note 197, at 56 (emphasis in original).  
201  See Eugenia Chan, Quality of Efficacy Research in Complementary and Alternative Medicine, 299 
JAMA 2685, 2686 (2008); Ernst, supra note 199; Ginger Polich et al., The Need to Act a Little 
More 'Scientific': Biomedical Researchers Investigating Complementary and Alternative Medicine, 
32 SOC. HEALTH & ILLNESS 106 (2010). 
202  KOPIT, supra note 197, at xvi. 
203  Id. at 67. 
204 Id. at 70. 
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gently responds, “I don’t really know,” humbly acknowledging the 
limitations of communicative science.205 
The implications of health professionals pushing for therapeutic 
advances to modify the destiny of an individual with a 
communicative disorder are also highlighted in Mark Medoff’s 
Children of a Lesser God.206  Sarah’s fate was altered by a sensory 
neural defect likely caused by prenatal rubella or a familial recessive 
trait, described by her speech pathologist husband, James, as “not 
correctable by surgery.”207  Sarah expresses great frustration with 
what she perceives to be the medical community’s attempt to impose 
their values on her, interfering with her right to decide how best to 
live her life in a predominantly hearing world whether with sign 
language, lip reading, or oral communication.208 
Although this 1979 play was penned well before cochlear 
implants, the ethical implications raised by attempts to shape a 
“normal” life with medical advances continue to be debated.209  
Another related contemporary controversy is the ethical dilemma of 
deaf parents who choose to use genetic technology to create a deaf 
child, rather than a hearing child.210  Who decides if new innovations 
205  Id. 
206  See MEDOFF, supra note 17. 
207  See Id. at 39. 
208  See Kathleen S. Arnos et al., Genetic Counseling of the Deaf. Medical and Cultural 
Considerations, 630 ANNALS N.Y. ACAD. SCI. 212 (1991); Patrick Boudreault et al., Deaf Adults’ 
Reasons for Genetic Testing Depend on Cultural Affiliation: Results from a Prospective, 
Longitudinal Genetic Counseling and Testing Study, 15 J. DEAF STUD. & DEAF EDUC. 209 (2010); 
NATIONAL ASS’N FOR THE DEAF, NAD POSITION PAPER ON ASL AND BILINGUAL EDUCATION 
(1993); NATIONAL ASS’N FOR THE DEAF, POSITION STATEMENT ON AMERICAN SIGN LANGUAGE 
(2008), http://www.nad.org/issues/american-sign-language/position-statement-american-
sign-language-2008. 
209  See Robert A. Crouch, Letting the Deaf Be Deaf: Reconsidering the Use of Cochlear Implants in 
Prelingually Deaf Children, HASTINGS CENTER REP., July-Aug. 1997, at 14, 14-15; Harlan Lane 
& Michael Grodin, Ethical Issues in Cochlear Implant Surgery: An Exploration into Disease, 
Disability, and the Best Interests of the Child, 7 KENNEDY INST. ETHICS J. 231, 237-38 (1997); Neil 
Levy, Reconsidering Cochlear Implants: The Lessons of Martha’s Vineyard, 16 BIOETHICS 134, 134-
35 (2002). 
210  See C. Mand et al., Genetic Selection for Deafness: The Views of Hearing Children of Deaf Adults, 
35 J. MED. ETHICS 722, 723 (2009); Trevor Johnston, In One’s Own Image: Ethics and the 
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are beneficial and to whom?  How do these judgments reflect societal 
norms? 
Sarah first reflects: 
For all my life I have been the creation of other people.  The first thing I 
was ever able to understand was that everyone was supposed to hear 
but I couldn’t and that was bad. . . . Well, my brain understands a lot, 
and my eyes are my ears; and my hands are my voice; and my 
language, my speech, my ability to communicate is as great as yours. 
Greater, maybe, because I can communicate to you in one image an 
idea more complex than you can speak to each other in fifty words.211 
Later in frustration, James lashes out at her: 
You want to be independent of me, you want to be a person in your 
own right, you want people not to pity you, but you want them to 
understand you in the very poetic way you describe in your speech as 
well as the plain old, boring way normal people understand each other, 
then you learn to read my lips and . . . I want you to speak to me. Let 
me hear . . . .212 
James’ strivings to make her more “normal” in a hearing world 
by forcing her to lip read is in direct opposition to Sarah’s choice to 
solely use sign language as her means of communicating with others. 
This push-pull to control the magic of sound creates great difficulty 
within their relationship as Sarah and James strongly disagree on 
how she should connect with both the hearing-impaired and non-
deaf community and who holds the key to her destiny? 
Who controls the fate of how one’s inner thoughts may be 
communicated to others is also dramatized by John Pielmeier’s Agnes 
of God.213  In this 1982 play, the wonders and enigma of science and 
fate are brought to life through hypnotism.214  Experimenting with 
Reproduction of Deafness, 10 J. DEAF STUD. & DEAF EDUC. 426, 430-31 (2005). 
211  MEDOFF, supra note 17, at 65. 
212  Id. at 67 (emphasis in original). 
213  PIELMEIER, supra note 18. 
214  See C.L. Copeland & E. Howard Kitching, Hypnosis in Mental Hospital Practice, 83 BRIT. J.
PSYCHIATRY 316 (1937); Giuliana Mazzoni et al., Suggested Visual Hallucinations in and out of 
Hypnosis, 18 CONSCIOUSNESS & COGNITION 494 (2009); Richard S. Sandor, Hypnosis as an 
"Entree" for Consultation-Liaison Psychiatry, 2 GEN. HOSP. PSYCHIATRY 65 (1980). 
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this technique as part of a court-ordered psychiatric evaluation,215 Dr. 
Livingstone takes control to clarify Agnes’s role in the death of a 
newborn.  The battle over the revelation of Agnes’s torturous hidden 
past is played out by the religious Mother and the psychiatrist, and 
ultimately Agnes’s unconscious silence is unlocked through 
hypnosis.216  The Mother remains concerned that all the doctor is 
“looking for” is “Plausibility!”217  She is distrustful because it is her 
belief “that it is also the nature of science to wonder, and we can only 
wonder if we are willing to question without finding all the 
answers.”218  When the doctor declares: “we can find them,” the 
Mother remains adamant: “You can look for them.  There’s a 
difference.  You’ll never find the answer to everything, Doctor. . . .  
The wonder of science is not in the answers it provides but in the 
questions it uncovers.”219  To which Dr. Livingstone firmly replies: 
“But she’s not an enigma.  Everything that Agnes has done is 
explainable by modern psychiatry.”220 
Agnes of God, like Equus, dramatizes the ethical and legal 
implications of a doctor having the power to use techniques that can 
change a patient’s destiny, particularly when the legal system has 
ordered psychiatric intervention and it is unclear whether the 
benefits outweigh the risks and for whom.221  Recent innovations in 
high-resolution functional neural imaging, used to unveil 
unconscious or purposefully deceptive thoughts, raise similar issues 
for society—especially since some critics question their scientific 
validity.222 
215  See APPELBAUM ET AL., supra note 124. 
216  See PIELMEIER, supra note 18. 
217  Id. at 61. 
218 Id. 
219  Id. at 61-62. 
220  Id. at 62. 
221  See PAUL S. APPELBAUM & THOMAS G. GUTHEIL, CLINICAL HANDBOOK OF PSYCHIATRY & THE 
LAW (4th ed. 2007); H.W. LeBourgeois, III, et al., Hindsight Bias Among Psychiatrists, 35 J. AM. 
ACAD. PSYCHIATRY & LAW 67 (2007).  
222  See THE OXFORD HANDBOOK OF NEUROETHICS (Judy Illes & B.J. Sahakian eds., 2011); George 
Annas, Foreword: Imagining a New Era of Neuroimaging, Neuroethics, and Neurolaw, 33 AM. J.L. 
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Contrary to the earlier plays that highlight the frustrations with 
trying to cure neuropsychiatric disorders and the motivations to 
create and experiment with pharmacological agents, Harold Pinter’s 
1982 play, A Kind of Alaska,223 illuminates the power of the fate-
changing invention of L-Dopa,224 a miracle drug that enabled 
institutionalized patients with encephalitis lethargic to instantly wake 
up after decades of “sleeping sickness” brought on by the 1917 flu 
epidemic.225  Inspired by Oliver Sacks’ book, Awakenings,226 and part 
of Pinter’s aptly named theatrical collection Other Places, the 
playwright portrays the wonder of science through the dialogue of 
Deborah and her neurologist Dr. Hornby, who so radically changes 
her destiny after three decades of a coma-like state.227  The play also 
illuminates the very real ethical and medical challenges posed by 
neurological uncertainty in the context of disorders of 
consciousness,228 while several high profile cases have played out in 
the courts and media.229  Scientists are now exploring how emerging 
& MED. 163, 167-68 (2007). 
223  HAROLD PINTER, A KIND OF ALASKA (1982), reprinted in OTHER PLACES : FOUR PLAYS 11 
(Dramatists 1984). 
224  See Arvid Carlsson et al., 3,4-Dihydroxyphenylalanine and 5-Hydroxytryptophan as Reserpine 
Antagonists, 180 NATURE 1200 (1957) 
225  See G.C. Cotzias, L-Dopa for Parkinsonism, 278 NEW ENG. J. MED. 630 (1968); R.T. Ravenholt & 
William H. Foege, 1918 Influenza, Encephalitis Lethargica, Parkinsonism, 320 LANCET 860 
(1982); Ann H. Reid et al., Experimenting on the Past: The Enigma of Von Economo’s Encephalitis 
Lethargica, 60 J. NEUROPATHOLOGY & EXPERIMENTAL NEUROLOGY 663 (2001). 
226  OLIVER SACKS, AWAKENINGS (rev. ed. 1990). 
227  See PINTER, supra note 223. 
228  See JEROME B. POSNER ET AL., PLUM AND POSNER'S DIAGNOSIS OF STUPOR AND COMA (4th ed. 
2007); Joseph J. Fins et al., Late Recovery from the Minimally Conscious State: Ethical and Policy 
Implications, 68 NEUROLOGY 304 (2007); Nicholas D. Schiff & Joseph J. Fins, Disorders of 
Consciousness, 82 MAYO CLINIC PROCEEDINGS 250 (2007).  
229  See GREGORY E. PENCE, CLASSIC CASES IN MEDICAL ETHICS: ACCOUNTS OF CASES THAT HAVE 
SHAPED MEDICAL ETHICS, WITH PHILOSOPHICAL, LEGAL, AND HISTORICAL BACKGROUNDS 29-55 
(3d ed. 2000); SANDRA H. JOHNSON ET AL., Quinlan and Cruzan: Beyond the Symbols, in 
HEALTH LAW AND BIOETHICS: CASES IN CONTEXT 53-73 (2009); Eric J. Cassell, The Schiavo Case: 
A Medical Perspective, HASTINGS CENTER REP., May-June 2005, at 22; Rebecca Dresser, 
Schiavo’s Legacy: The Need for an Objective Standard, HASTINGS CENTER REP., May-June 2005, at 
20; Jay Wolfson, Erring on the Side of Theresa Schiavo: Reflections of the Special Guardian Ad 
Litem, HASTINGS CENTER REP., May-June 2005, at 16. 
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high resolution neuroimaging technologies can more accurately 
diagnose levels of awareness, to potentially provide a path to 
rehabilitation for some who are not in a persistent vegetative state.230 
When Deborah asks Dr. Hornby, “How did you wake me up? 
Or did you not wake me up?  Did I just wake up myself?  All by 
myself?  Or did you wake me with a magic wand?”  Dr. Hornby 
explains, “I woke you with an injection,” 231 and goes on to clarify: 
I have been your doctor for many years.  This is your sister.  Your 
father is blind. . . . Your mother is dead. . . . I lifted you onto this bed, 
like a corpse.  Some wanted to bury you.  I forbade it.  I have nourished 
you, watched over you, for all this time.  I injected you and woke you 
up.  You will ask why I did not inject you twenty-nine years ago.  I’ll 
tell you.  I did not possess the appropriate fluid. . . . You see, you have 
been nowhere, absent, indifferent.  It is we who have suffered.232 
This positive image of Deborah suddenly rising from an 
unanimated state because of a scientific innovation is juxtaposed with 
the negative image of the creation of Frankenstein.  In fact, during the 
same time period of Pinter’s Kind of Alaska,233 Victor Gialanella 
authored yet another adaptation of Shelley’s Frankenstein.234  This 
rendition is considered by many scholars to be the most authentic to 
Shelley’s novel since Presumption; or, The Fate of Frankenstein,235 
written 160 years earlier.  In Gialanella’s play, Dr. Victor 
Frankenstein, his assistant Henry, and the Creature question how the 
destructive power of technological feats can radically alter the 
destiny of many.  The timing of this play coincided with ethical 
controversy over gene therapy and concern about modifying the 
230  See Jonathan C. Bardin et al., Dissociations between Behavioural and Functional Magnetic 
Resonance Imaging-Based Evaluations of Cognitive Function after Brain Injury, 134 BRAIN: J. 
NEUROLOGY 769 (2011); Joseph J. Fins & Nicholas D. Schiff, The Afterlife of Terri Schiavo, 
HASTINGS CENTER REP., July-Aug. 2005, at 8; Nicholas D. Schiff et al., Deep Brain Stimulation, 
Neuroethics, and the Minimally Conscious State: Moving Beyond Proof of Principle, 66 ARCHIVES 
NEUROLOGY 697 (2009). 
231  PINTER, supra note 223, at 15. 
232  Id. at 34. 
233  PINTER, supra note 223. 
234  VICTOR GIALANELLA, FRANKENSTEIN (Dramatists 1982); SHELLEY, supra note 30. 
235  See PEAKE, supra note 4 and accompanying text. 
KAREN H. ROTHENBERG & LYNN W. BUSH 39
germ line,236 as well as the awe and fears of experimenting with 
artificial hearts in humans.237 
In a scene vividly capturing the blind ambition of Frankenstein 
for scientific advancement at all costs, he exclaims: 
Henry, I have reason to believe that I am capable of re-animating 
life. . . . The creation of life . . . in a man. (Thunder). . . . I have in my 
laboratory the intelligent brain of one man and the healthy heart of 
another, kept alive by means of induction through chemicals for well 
beyond a week. . . . I have only been awaiting a proper vessel in which 
they are to be implanted. . . . The only struggle that remains is the 
completion of the surgery before the storm has reached its peak, and in 
this you can help me. . . . To have control of life and death.  Perhaps to 
remove disease forever from the human frame.  To insure eternally the 
existence of the greatest minds.238 
After Henry expresses his disbelief that “there is no basis for this 
procedure anywhere in modern science,” Victor proclaims “that, to 
me, is the great challenge of the sciences; to go beyond what anyone 
has done before”239 and with excitement adds: “Can you feel it, 
Henry?  The excitement, the power? . . . The culmination of my work. 
We stand at the threshold of a new age of man.  The dawn of a new 
236  See LEROY WALTERS & JULIE GAGE PALMER, THE ETHICS OF HUMAN GENE THERAPY 76-77 
(1997); John C. Fletcher, Evolution of Ethical Debate About Human Gene Therapy, 1 HUMAN 
GENE THERAPY 55, 61-65 (1990); John C. Fletcher & W. French Anderson, Germ-Line Gene 
Therapy: A New Stage of Debate, 20 LAW, MED. & HEALTH CARE 26, 27 (1992); Erik Parens, 
Should We Hold the (Germ) Line?, 23 J.L. MED. & ETHICS 173, 173 (1995); LeRoy Walters, 
Human Gene Therapy: Ethics and Public Policy, 2 HUMAN GENE THERAPY 115, 116 (1991); 
LeRoy Walters, Genetics and Bioethics: How Our Thinking Has Changed Since 1969, 33 
THEORETICAL MED. & BIOETHICS 83, 86-7 (2012); Nelson A. Wivel & LeRoy Walters, Germ-
Line Gene Modification and Disease Prevention: Some Medical and Ethical Perspectives, 262 
SCIENCE 533, 535-36 (1993). 
237  See George J. Annas, Consent to the Artificial Heart: The Lion and the Crocodiles, HASTINGS CTR.
REP., Apr. 1983, at 20, 20; William C. DeVries et al., Clinical Use of the Total Artificial Heart, 310 
NEW ENG. J. MED.  273, 273 (1984); Thomas A. Preston, Who Benefits from the Artificial Heart?, 
HASTINGS CENTER REP., Jan.-Feb. 1985 at  5; James Rachels, Barney Clark’s Key, HASTINGS 
CENTER REP., Apr. 1983 at 17, 17; Michael J. Strauss, The Political History of the Artificial Heart, 
310 NEW ENG. J. MED. 332, 334 (1984). 
238  GIALANELLA, supra note 234, at 19-20. 
239  Id. at 21-22. 
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species who will bless us as their creators. (He moves to the control 
panel.)”240 
Later in the play, Victor reflects on the consequences of his 
actions to the Creature: “Do you think that I am free of guilt?  Of 
pain?  Of Responsibility?”  To which the Creature responds: “No. 
For it was you who gave me life. . . . I have destroyed you and 
everything you ever loved.  I shall die as you are dead.”  The 
Creature then adds, “But we will at last be bound together, forever all 
alone.  (He rises and crosses to the bank of switches.)  And thus the 
instruments of life become the instruments of death.”241 
ACT IV: AIDS & EVERS 
Whereas Frankenstein exemplifies scientific innovation that 
surges out of control, the mid-1980s found both the medical 
community and the public confronted with a new and poorly 
understood infectious disease that was raging out of control—
Acquired Immune Deficiency Syndrome (AIDS).242  Several 
playwrights seized upon the opportunity to portray the evolution of 
this mysterious killer that would first grip the gay community and 
highlight the desperate search to gain control through innovations in 
medicine. 
Larry Kramer’s The Normal Heart243 provides a memorable 
platform for the theatre.  Kramer’s play captures the frustration of 
medical uncertainty and ethical dilemmas244 through the character of 
240  Id. at 23. 
241  Id. at 60. 
242  See Carol Levine & Joyce Bermel, AIDS: The Emerging Ethical Dilemmas, in HASTINGS CENTER 
REPORT (Supp. 1985); see also Ronald Bayer & Amy L. Fairchild, The Genesis of Public Health 
Ethics, 18 BIOETHICS 476, 478 (2004). 
243  KRAMER, supra note 19. 
244  See Renée C. Fox, The Evolution of Medical Uncertainty, 58 MILBANK MEMORIAL FUND Q. 
HEALTH & SOC’Y 1, 13 (1980); Robert Steinbrook et al., Ethical Dilemmas in Caring for Patients 
with the Acquired Immunodeficiency Syndrome, 103 ANNALS INTERNAL MED. 787, 787 (1985). 
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Dr. Emma Brookner: 
And even if they found out tomorrow what’s happening, it takes years 
to find out how to cure and prevent anything.  All I know is this 
disease is the most insidious killer I’ve ever seen or studied or heard 
about.  And I think we’re seeing only the tip of the iceberg.245 
Emma further clarifies: 
Long before we isolated the hepatitis viruses we knew about the 
diseases they caused and had a good idea of how they got around. . . . I 
am seeing more cases each week than the week before.  I figure that by 
the end of the year the number will be doubling every six months.246 
She desperately experiments with interventions in an attempt to 
control the ravaging disease of so many of her patients, including gay 
rights activist Ned Weeks and his lover Felix Turner.247 
Kramer’s powerful dialogue further explores how attitudes on 
the morality of homosexuality can blind society to the urgency of 
addressing a stigmatizing, major public health threat—much like the 
dynamic witnessed in Spirochete.248 The Normal Heart captures how 
complex relationships among the gay community, medical profession 
and government officials all played roles—both positive and 
negative—in the search for innovative strategies to understand the 
cause, prevention and treatment of AIDS.249  When Ned expresses his 
fear that “we’re just walking time bombs—waiting for whatever it is 
that sets us off,” Emma recognizes that “before a vaccine can be 
discovered almost every gay man will have been exposed.”250  To 
245  KRAMER, supra note 19, at 22. 
246  Id. at 27. 
247  See id. 
248  See Sundgaard, supra notes 13, 104-09 and accompanying text; RONALD BAYER, PRIVATE 
ACTS, SOCIAL CONSEQUENCES: AIDS AND THE POLITICS OF PUBLIC HEALTH (1989); ERVING 
GOFFMAN, STIGMA: NOTES ON THE MANAGEMENT OF SPOILED IDENTITY (1963). 
249  See Lawrence O. Gostin, HIV Screening in Health Care Settings: Public Health and Civil Liberties 
in Conflict?, 296 JAMA 2023 (2006); Larry Gostin, Vaccination for AIDS: Legal and Ethical 
Challenges from the Test Tube, to the Human Subject, Through to the Marketplace, 2 AIDS PUB. 
POL’Y J. 9 (1987); Hoffman, supra note 112. 
250  KRAMER, supra note 19, at 70. 
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which Ned retorts, “Where’s the goddamned AMA in all of this? The 
government has not started one single test tube of research. Where’s 
the board of directors of your very own hospital?”251 
When Emma later suggests to Ned an experimental “treatment of 
several chemotherapies used together,”252 she acknowledges: 
[Y]ou won’t get particularly good care anywhere, maybe not even here. 
At . . . I’ll call it Hospital A, you’ll come under a group of mad 
scientists, research fanatics, who will try almost anything and if you 
die you die. . . . you’ll just be a statistic for their computer—which they 
won’t share with anyone else, by the way; there’s not much sharing 
going on, never is—you’ll be a true guinea pig.  At Hospital B, they 
decided they really didn’t want to get involved with this, it’s too 
messy . . .  C is like the New York Times and our friends everywhere: 
square, righteous, superior, and embarrassed by this disease and this 
entire epidemic . . . Why am I telling you this?  I must be insane.  But 
the situation is insane.253 
As it became clear that AIDS was spreading out of control with 
no hope in sight, the scientists, physicians, community activists, 
politicians and society at large were struggling to find their moral 
compass to guide them on how best to control the fate of this disease. 
By the beginning of the 1990s the fears, frustrations and stigma of 
the diagnosis of AIDS were further explored by Tony Kushner in his 
two plays, the Pulitzer Prize-winning Millennium Approaches 254 and 
Perestroika,255 eventually combined as Angels in America.256 The ethical 
implications of human experimentation and allocation of scarce 
resources for innovative drugs and new treatment modalities257 are 
251  Id. at 72. 
252  Id. at 85. 
253  Id. at 85-86. 
254  TONY KUSHNER, Angels in America, Part One: Millennium Approaches, in ANGELS IN AMERICA:
A GAY FANTASIA ON NATIONAL THEMES 1 (Theatre Commc’ns Grp. 2003) (1992). 
255  TONY KUSHNER, Angels in America, Part Two: Perestroika, in ANGELS IN AMERICA: A GAY 
FANTASIA ON NATIONAL THEMES 127 (Theatre Commc’ns Grp. 2003) (1992).  
256  KUSHNER, supra note 20. 
257  See Ruth R. Faden & Nancy E. Kass, Bioethics and Public Health in the 1980s: Resource 
Allocation and AIDS, 12 ANN. REV. PUB. HEALTH 335 (1991); Lawrence Gostin & Jonathan M. 
Mann, Towards the Development of a Human Rights Impact Assessment for the Formulation and 
Evaluation of Public Health Policies, 1 HEALTH & HUM. RTS. 58 (1994); Lawrence O. Gostin & 
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illuminated in Millennium through dialogue between the conservative 
powerbroker Roy Cohn and his physician Henry.  When Henry tells 
Roy “You have AIDS,” Roy rejects that diagnosis and declares “AIDS 
is what homosexuals have. I have liver cancer.”258  Henry disagrees: 
Well, whatever the fuck you have, Roy, it’s very serious, and I haven’t 
got a damn thing for you.  The NIH in Bethesda has a new drug called 
AZT with a two-year waiting list that not even I can get you onto.  So 
get on the phone . . . and tell the First Lady you need in on an 
experimental treatment for liver cancer, because you can call it any 
damn thing you want, Roy, but what it boils down to is very bad 
news.259 
In Perestroika, the ethical implications of experimental 
interventions, including fair access to clinical trials and 
randomization,260 are further examined in dialogue between Roy 
Cohn and the nurse Belize. “They have you down for radiation 
tomorrow for the sarcoma lesions, and you don’t want to let them do 
that, because radiation will kill the T-cells and you don’t have any 
you can afford to lose,” says Belize.  He urges: “So tell the doctor no 
thanks for the radiation.  He won’t want to listen.  Persuade him.  Or 
he’ll kill you.”261 
Although Roy manages to “get in on the azidothymidine [AZT] 
trials” Belize cautions, “Watch out for the double blind.  They’ll want 
you to sign something that says they can give you M&M’s instead of 
the real drug.  You’ll die, but they’ll get the kind of statistics they can 
publish in the New England Journal of Medicine.”  Reminding Roy of 
the reality of gaining access to experimental treatment, Belize adds: 
“And if you don’t sign, no pills.  So if you have any strings left, pull 
them, because everyone’s put through the double blind and with this, 
time’s against you, you can’t fuck around with placebos.”262  Belize 
Susan C. Kim, Ethical Allocation of Preexposure HIV Prophylaxis, 305 JAMA 191 (2011). 
258  KUSHNER, MILLENNIUM APPROACHES, supra note 254, at 52.  
259  Id.  
260  See Robert J. Levine, The Impact of HIV Infection on Society’s Perception of Clinical Trials, 4 
KENNEDY INST. ETHICS J. 93 (1994); Peter A. Ubel & Robert Silbergleit, Behavioral Equipoise: A 
Way to Resolve Ethical Stalemate in Clinical Research, 11 AM. J. BIOETHICS 1 (2011). 
261  KUSHNER, PERESTROIKA, supra note 255, at 159–60. 
262  Id. at 160. 
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brings to life the controversy concerning the ethics of randomized 
clinical trials when there are no other potential avenues for medical 
or pharmacological intervention.263 
The financial and institutional implications of bringing forth 
AIDS research into clinical care are tackled in Larry Kramer’s The 
Destiny of Me.264  This 1992 play, a sequel to The Normal Heart,265 
explores the power and limitations of an NIH physician–scientist, 
Tony Della Vida, attempting to control the fate of AIDS when 
confronted with both scientific and political challenges.266  Reading 
from various journal clippings, Ned Weeks mocks the research 
establishment: 
‘[R]econstituted genes will be introduced in transfusions of the 
patient’s own blood . . .  cells given new genetic instructions, to self-
destruct if they are infected.’  The Lancet. . . . ‘Conclusion: The success 
of this theory in in vitro experiments, followed by the successful 
inoculation of three West African sooty mangabey monkeys, leads one 
to hope that human experimentation can commence without further 
delay.’ The New England Journal of Monkeys.  I’ll be your monkey.267 
In fact, Ned is desperate to try anything to save his life,268 a 
challenge posed by the informed consent process for research when 
therapeutic misconception clouds one’s objectivity.269  Tony wheels in 
his “Ex-Cell-Aerator,” explaining: “Your reassembled blood will be 
pumped through it so it can be exposed to particles of—”270 
263  See Samuel Hellman & Deborah Hellman, Of Mice But Not Men: Problems of the Randomized 
Clinical Trial, 324 N. ENG. J. MED. 1585 (2001). 
264  LARRY KRAMER, The Destiny of Me (1992), in THE NORMAL HEART AND THE DESTINY OF ME :
TWO PLAYS BY LARRY KRAMER 1 (Grove Press 2000). 
265  KRAMER, THE NORMAL HEART, supra note 19. 
266  See Harold Edgar & David J. Rothman, New Rules for New Drugs: The Challenge of AIDS to the 
Regulatory Process, 68 MILBANK Q. 111 (Supp. 1990). 
267  KRAMER, supra note 264, at 141. 
268  See Paul S. Appelbaum et al., Voluntariness of Consent to Research: A Conceptual Model, 39 
HASTINGS CENTER REP. 30 (2009). 
269  See Paul S. Appelbaum et al., The Therapeutic Misconception: Informed Consent in Psychiatric 
Research, 5 INT’L J.L. & PSYCHIATRY 319 (1982) 
270  KRAMER, supra note 264, at 228. 
KAREN H. ROTHENBERG & LYNN W. BUSH 45
Astonished, Ned asks: “Did you dream all this up?” and Tony 
quickly responds: “I try to be as creative as the law allows.”271  When 
Ned queries, “Do genes get loose and act uncontrollably, like 
viruses,” Tony confirms: “You bet.  It’s scary trying to modify 
nature.”272  The play dramatizes the vacillation between optimism 
and skepticism in finding the cure that could change Ned’s destiny, 
as well the professional destiny of Tony when forced to consider a 
multitude of bioethical and political challenges—highlighting the 
limits of what a scientist can attempt in good faith when trying to 
discover an effective intervention.273 
That same year gave rise to another powerful theatrical 
production that glaringly illuminated the ethical ramifications of 
withholding advances in medication to vulnerable populations 
during research protocols.274  While the AIDS plays reflected the 
changing landscape where research was sought after as a benefit to 
attain innovative medicine,275 David Feldshuh’s Miss Evers’ Boys276 
shines a brutal light on the Tuskegee Study277 where risks were 
271  Id. at 229. 
272  Id.  
273  See Renée C. Fox, Advanced Medical Technology -- Social and Ethical Implications, 2 ANN. REV.
SOC. 231 (1976). 
274  See Allan M. Brandt, Racism and Research: The Case of the Tuskegee Syphilis Study, 8 HASTINGS 
CENTER REP. 21 (Dec. 1978); Troy Duster, Lessons from History: Why Race and Ethnicity Have 
Played a Major Role in Biomedical Research, 34 J.L. MED. & ETHICS 487, 491 (2006); See generally 
Dorothy E. Roberts, Legal Constraints on the Use of Race in Biomedical Research: Toward a Social 
Justice Framework, 34 J.L. MED. & ETHICS 526 (2006). 
275  See R. Steinbrook et al., Ethical Dilemmas in Caring for Patients with the Acquired 
Immunodeficiency Syndrome, 103 ANNALS INTERNAL MED. 787 (1985); THE MEANING OF AIDS: 
IMPLICATIONS FOR MEDICAL SCIENCE, CLINICAL PRACTICE AND PUBLIC HEALTH POLICY (Eric 
Juengst & Barbara Koenig eds., 1989). 
276  FELDSHUH, supra note 21. 
277  See generally TUSKEGEE’S TRUTHS: RETHINKING THE TUSKEGEE SYPHILIS STUDY (Susan Reverby 
ed., 2000); FINAL REPORT OF THE TUSKEGEE SYPHILIS STUDY LEGACY COMMITTEE (May 20, 
1996), available at http://www.hsl.virginia.edu/historical/medical_history/bad_blood/ 
 report.cfm. 
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allowed to fester, and benefits would go to others.278  Inspired in part 
by James Jones’s true story, Bad Blood,279 the Tuskegee men were 
inhumanely refused what became standard of care treatment since 
penicillin was developed soon after they began participating in the 
syphilis research in 1932 and was withheld for four decades.280 
Few events in the history of human experimentation have 
resonated with so much moral disequilibrium as Tuskegee,281 and are 
dramatically captured in the dialogue among Douglas, the white field 
physician from the Public Health Service, Miss Evers, the black 
public health nurse, and Brodus, the black administrative head of 
Tuskegee Hospital.  “We have a perfect laboratory here: a fixed 
population, virtually untreated disease,” declares Douglas to his 
colleagues; “A study could be created and carried out with minimal 
expense.  And it would be the most important study of its kind ever 
conducted.”282 
Evers reacts with concern that “those patients need medicine.”283  
But Douglas continues: “We follow these patients for six months. We 
catalogue what this disease untreated does to them. And then we let 
the facts speak for themselves,”284 and “[a]s long as this research 
continues, any study patient that dies for whatever reason receives 
fifty dollars, for burial.  I could fight and get that much money, Nurse 
278  See Allan M. Brandt, The Syphilis Epidemic and its Relation to AIDS, 239 SCIENCE 375, 378 
(1988). 
279  JAMES JONES, BAD BLOOD: THE TUSKEGEE SYPHILIS EXPERIMENT (1981). 
280  See generally A.N. Richards, Production of Penicillin in the United States (1941-1946), 201 
NATURE 441 (1964). 
281  See U.S. Dep’t Health, Ed. & Welfare, FINAL REPORT OF THE TUSKEGEE SYPHILIS STUDY AD 
HOC ADVISORY PANEL (1973); SUSAN M. REVERBY, EXAMINING TUSKEGEE: THE INFAMOUS 
SYPHILIS STUDY AND ITS LEGACY (2009); Press Release from Bill Clinton, President of the 
United States, Remarks by the President in Apology for Study Done in Tuskegee (May 16, 
1997), available at http://www.cdc.gov/tuskegee/clintonp.htm; see also PRESIDENTIAL 
COMMISSION FOR THE STUDY OF BIOETHICAL ISSUES, “ETHICALLY IMPOSSIBLE:” STD RESEARCH 
IN GUATEMALA FROM 1946 TO 1948 (2011). 
282  FELDSHUH, supra note 21, at 40. 
283  Id. 
284  Id. at 40. 
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Evers, if it would convince those men to stay in the study.”285  As 
some time passes and the deception and experiment continues,286 
Evers speaks up: “I just want to tell the men what’s going on.  The 
straight truth. ‘There’s no mercury in those back rubs.  They won’t 
stop bad blood.  But you got to stick with it so when new money 
comes you’ll be right up front, first in line . . .’  The straight truth.”287  
Evers tries to justify her role: “I’m a nurse.  I’m not a scientist,” but 
Brodus clearly asserts: “There is no difference.  Not here.  Not 
now.”288 
Many decades later, when Feldshuh fictionalizes Evers’ 
testimony before Congress289 on the continuing unethical practices, 
Nurse Evers tries to justify why their protocol was not altered despite 
advances in medical interventions over time: 
When you’re up close . . . you don’t notice the changes. . . . Unless they 
catch you by surprise. . . . . . I’m not saying there weren’t consequences. 
I’m just saying it wasn’t that simple.  The disease was not predictable. 
And there was no money.  And the treatment was dangerous.290 
Evers further reflects: “But 1946 changed all that. Something new 
arrived, something that changed everything.  The ‘silver bullet,’ they  
285  Id. at 44. 
286  RUTH R. FADEN ET AL., A HISTORY AND THEORY OF INFORMED CONSENT 165-67 (1986). 
287  FELDSHUH, supra note 21, at 55. 
288  Id.  
289  See Rothenberg, supra note 2, at 424 n.104; National Research Act of 1974, Pub. L. No. 93-
348, 88 Stat. 342. See also S. REP. NO. 93-381, pt. 11 (1974) reprinted in 1974 U.S.C.C.A.N 3643, 
3655.  The nurse on whom Nurse Evers is based, Eunice Rivers, co-wrote an article on her 
role in the Tuskegee program in 1953. Eunice Rivers et al., Twenty Years of Followup 
Experience in a Long-Range Medical Study, 68 PUB. HEALTH REP. 391 (1953).  She never testified 
before Congress, however.  SUSAN M. REVERBY, TUSKEGEE’S TRUTHS: RETHINKING THE 
TUSKEGEE SYPHILIS STUDY 371 (2000) (“When the story of the experiment broke in the press 
in 1972, Nurse Rivers retreated into a form of silence.  She refused most interviews, did not 
give testimony before the Senate hearing, and only allowed herself to be interviewed once 
by the federal investigating team.”). 
290  FELDSHUH, supra note 21, at 63. 
48 HOUS. J. HEALTH L. & POL’Y
called it: penicillin. . . . And my patients were going to be first in 
line.”291  However, that never happened. 
This historical watershed is further brought to life by Caleb and 
Ben, two of Miss Evers’ “boys,” who were unable to attain innovative 
medicine because of the unethical decisions made by many in the 
medical and public health community—including Nurse Evers. 
When Caleb recognizes “how in God’s heaven are we going to get 
well unless we try something new,” he shares his observation: 
“[E]very which way you can see men in this county are lining up 
getting this medicine and walking out free and easy. . . .  [saying] ‘I 
got bad blood. Gonna get me penicillin.’”292  When Caleb asks, “And 
what we do?,”  Ben responds, “Nurse Evers don’t want us to get that 
medicine”; to which Caleb declares: “They all keeping us from that 
medicine.”293 The dramatic potential of this story of deception and 
unethical research practices—which led to the promulgation of 
federal regulations to protect research participants294—is reminiscent 
of many earlier plays, including Woyzeck and the legacy of 
Frankenstein.  Moreover, as witnessed in Spirochete, there became a 
critical point in time when the discovery of a drug could make all the 
difference for a blind baby’s future;295 withholding that same 
innovation destroyed the lives of Miss Evers’ Boys. 
291  Id. at 64. 
292  Id. at 79. 
293  Id. at 79-80. 
294  By 1981, the “Common Rule” was adopted. 45 C.F.R. § 46.101(a) (2011).  In July 2011, the 
Federal Register published an Advance Notice of Proposed Rulemaking (ANPRM) 
regarding amendments to the “Common Rule.” See HHS, Human Subjects Research 
Protections: Enhancing Protections for Research Subjects and Reducing Burden, Delay, and 
Ambiguity for Investigators, 76 Fed. Reg. 44,512, 44,523 (July 26, 2011) (to be codified at 45 
C.F.R. pts. 46, 160, 164 and 21 C.F.R. pts. 50, 56). See RAND Corp., Proposed Directions of 
Change to the Common Rule for Protecting Human Research Participants (Oct. 25, 2011), available 
at http://www.rand.org/pubs/corporate_pubs/CP659.html; Ezekiel J. Emanuel & Jerry 
Menikoff, Reforming the Regulations Governing Research with Human Subjects, 365 NEW. ENG. J. 
MED. 1145, 1145 (2011). 
295  See Sundgaard, supra notes 13, 104-09 and accompanying text. 
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ACT V: HI TECH, LOW TECH & NO TECH 
The discovery of the double helix in the 1950s also set the stage 
for new scientific discoveries generations later.296 In 1990, a massive 
research initiative—the Human Genome Project (HGP)—commenced 
to map the human genome and generate new information that had 
the potential to positively contribute to human health.297  In response 
to the major societal challenges posed by the HGP, an unprecedented 
amount of funding was allocated toward research on its ethical, legal, 
and social implications. 298  How do we allow the promise of science 
to move forward and at the same time keep in check the perils of 
what we learned?299  The HGP raised familiar questions about the 
social perception of normality and the potential for discrimination on 
the basis of race, disability, sexuality, class, and gender.300 
Although the HGP has provided remarkable technological 
advances that have put quite a distance between genetics and its 
296  Aaron Klug, The Discovery of the DNA Double Helix, 335 J. Mol. Biol. 3, 3 (2004). 
297  See Francis Collins & David Galas, A New Five-Year Plan for the U.S. Human Genome Project, 
262 SCIENCE, 43 (1993).  See generally All About the Human Genome Project (HGP), NAT’L 
HUMAN GENOME RESEARCH INST., http://www.genome.gov/10001772 (last updated Oct. 1, 
2012). 
298  See Eric T. Juengst, Self-Critical Federal Science? The Ethics Experiment Within the U.S. Human 
Genome Project, SOC. PHILOSOPHY & POL’Y FOUND. 63 (1996); Eric M. Meslin et al., The Ethical, 
Legal, and Social Implications Research Program at the National Human Genome Research Institute, 
7 KENNEDY INST. ETHICS J. 291 (1997), available at http://muse.jhu.edu/journals/kennedy_ 
 institute_of_ethics_journal/v007/7.3meslin.html.  See generally The Ethical, Legal and Social 
Implications (ELSI) Research Program, NAT’L HUMAN GENOME RESEARCH INST., 
http://www.genome.gov/10001618 (last updated July 11, 2012).  
299  See Eric T. Juengst, The Human Genome Project and Bioethics, 1 KENNEDY INST. ETHICS J. 71 
(1991). 
300  See, e.g., TROY DUSTER, BACKDOOR TO EUGENICS (2d ed. 2003); Mark D. Schwartz et al., 
Consent to the Use of Stored DNA for Genetics Research: A Survey of attitudes in the Jewish 
Population, 98 AMER. J. OF MED. GENETICS 336 (2001); Francis S. Collins et al., A Vision for the 
Future of Genomics Research, 422 NATURE 835, 843-847 (2003); NAT’L HUMAN GENOME 
RESEARCH INST., A REVIEW AND ANALYSIS OF THE ETHICAL, LEGAL AND SOCIAL IMPLICATIONS 
(ELSI) RESEARCH PROGRAMS AT THE NATIONAL INSTITUTES OF HEALTH AND THE DEPARTMENT 
OF ENERGY, available at http://www.genome.gov/Pages/Research/DER/ELSI/erpeg_ 
 report.pdf.  See generally ELSI Research Priorities and Possible Research Projects, NAT’L HUMAN 
GENOME RESEARCH INST., http://www.genome.gov/27543732 (last updated July 18, 2011).  
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maligned predecessor eugenics,301 it continues to raise complex 
ethical issues ripe for dramatization in theatre.  Jonathan Tolins’ 1992 
play Twilight of the Golds introduces characters that raise many 
questions as to who should, or can, control the fate of future 
generations through the use of emerging prenatal genetic 
technology.302  Tensions rise when Suzanne learns that she is 
pregnant and, along with her geneticist husband Rob, decides to use 
fictionalized technology to test the fetus for the “gay” gene—
preoccupied with the concern that homosexuality will be inherited 
from her brother David.303  After learning the test is positive, Suzanne 
shares her hopes and disappointments: “This baby was going to 
change our lives and make everything better.  Not that things are 
bad.  . . . Now the whole thing is tainted. I wish we didn’t know, but 
we do. And it’s a problem.”304 
Such scientific developments raise the familiar question: are 
some lives not worth living to some individuals?  David reacts to his 
sister Suzanne’s decision to seek prenatal genetic testing: “What if 
you found out the kid was going to be ugly, or smell bad, or have an 
annoying laugh, or need really thick glasses?”305  David continues, 
“But where do we stop?  . . . So now we have this technology, what 
are we going to do with it?  It starts with us, Suzanne.”306  Later on, 
Rob responds, “Don’t put the fate of the world on our shoulders. We 
can’t carry the load.”307 
In order to dramatize the promises and perils of genetic 
technologies on pregnant women, personal relationships, and society 
301  See Rothenberg, supra note 2, at 422; but see DUSTER, supra note 300. 
302  TOLINS, supra note 22. 
303  See Rothenberg, supra note 2, at 426 n.113, 428 n.127 (noting studies challenging reports of a 
“gay” gene). See also Dean H. Hamer et al., A Linkage Between DNA Markers on the X 
Chromosome and Male Sexual Orientation, 261 SCIENCE 321 (1993).  See, e.g., Eliot Marshall, 
NIH “Gay Gene” Study Questioned, 268 SCIENCE 1841 (1995).  
304  TOLINS, supra note 22, at 78.  See Karen H. Rothenberg, The Law’s Response to Reproductive 
Genetic Testing: Questioning Assumptions About Choice, Causation, and Control, 8 FETAL 
DIAGNOSIS & THERAPY 160 (1993). 
305  Tolins, supra note 22, at 78. 
306  Id. 
307  TOLINS, supra note 22, at 87. 
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at large, Tolins juxtaposes Suzanne and David’s concerns with Rob’s 
excitement over the potential for science to control fate.  While Tolins 
recognizes the discriminatory potential of genetic testing, he also 
raises the question of whether scientific explanations will justify the 
rationale for biological control of homosexuality.  In fact, as Rob 
reflects, 
The power of the creator.  . . . [M]y road to a career in genetic research 
was paved with Lego.  I always had a fascination with components; 
how things are put together, how to take them apart, how to change 
them.  . . .  I sit there in the lab . . . and I think, why not with people? 
There’s obviously a lot . . . that needs to be corrected.  Or can at least be 
improved.  Just look at the amount of suffering, inward and outward, 
all around us. Let’s use every weapon we have to combat it. Is that 
such a horrible thing to think?308 
This question continues to be raised in a number of contexts 
when exploring the ethical implications of using new innovations in 
medicine to seek a semblance of normalcy. Yet what is “normal,” and 
who gets to decide?  These dilemmas, often raised in dramatic 
theatre, are again explored in Molly Sweeney,309 the 1994 Irish play by 
Brian Friel.  These concerns are alluded to earlier by the deaf 
character in Children of a Lesser God regarding language 
technologies,310 and become heightened when experimental eye 
surgery is promoted to partially restore the sight of Molly, blind since 
birth, by her husband Frank and physician Rice.  “And if there is a 
chance, any chance, that she might be able to see, we must take it, 
mustn’t we?  How can we not take it?  She has nothing to lose, has 
she? What has she to lose? —nothing!  —nothing!,” Rice offers 
enthusiastically.311 
Rice then considers, “the chance of a lifetime, the one-in-a-
thousand opportunity that can rescue a career—no, no, transform a 
career—dare I say it, restore a reputation?”312  “So, if her sight were 
308  Id. at 85. 
309  BRIAN FRIEL, MOLLY SWEENEY (1994) (Dramatists Play Service Inc. 1996). 
310  See MEDOFF, supra note 17, 206-12 and accompanying text. 
311  FRIEL, supra note 309, at 13.  
312  Id. at 14. 
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restored,” Frank reflects, “everything would have to be learned 
anew: she would have to learn to see.  . . . [S]he would have to create a 
whole new world of her own.”313  “And then with sudden anger,” 
Molly questions: 
[W]hy am I going for this operation?  None of this is my choosing. . . . I 
am being used. Of course I trust Frank.  Of course I trust Mr. Rice.  But 
how can they know what they are taking away from me?  How do they 
know what they are offering me?  They don’t. They can’t.  And have I 
anything to gain? – anything?314 
Ultimately, Frank and the physician Rice question the potential 
ethical implications of using medical innovations to intervene with 
fate.  While Frank rejoices that “ Molly was about to inherit a new 
world,” physician Rice worries that “even though she was in the 
hands of the best team in the whole world to deliver her miracle . . . I 
was fearful. I suddenly knew that this courageous woman had 
everything, everything to lose.”315  This emotional struggle for health 
professionals concerned with the efficacy of treatment and quality of 
life316 is reminiscent of Equus,317 Elephant Man,318 and Children of a 
Lesser God,319 amongst others. 
While the goal of the eye surgeon in Molly Sweeney was to use 
emerging technology to “better” his patient’s life, David Rabe’s play, 
A Question of Mercy, explores the ethical dilemmas of a physician 
being persuaded by a patient with AIDS to use technology to hasten 
death.320  The dialogue of this 1998 adaptation of Dr. Richard Seltzer’s 
313  Id. at 17. 
314  Id. at 25. 
315  Id. at 27, 32.  
316  See D.W. Forrest, Von Senden, Mesmer, and the Recovery of Sight in the Blind, 87 AM. J.
PSYCHOL. 719, 720 (1974); Daphne Maurer et al., Effects of Early Visual Deprivation on 
Perceptual and Cognitive Development, 164 PROGRESS IN BRAIN RES. 87, 101 (2007); Yuri 
Ostrovsky et al., Vision Following Extended Congenital Blindness, 17 PSYCHOL. SCI. 1009, 1013 
(2006). 
317  See SHAFFER, supra note 180-88 and accompanying text. 
318  See POMERANCE, supra note 189-96 and accompanying text. 
319  See MEDOFF, supra note 17, 206-12 and accompanying text. 
320  DAVID RABE, A QUESTION OF MERCY, 10 (Dramatists 1998). 
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1991 journal321 illuminates the conscious and unconscious 
ambivalence of Doctor Chapman—tortured between his desire to 
create the perfect plan for Anthony’s assisted suicide322 to ameliorate 
suffering and his longstanding commitment to abide by the 
Hippocratic Oath “to do no harm.”323 
Dr. Chapman reflects to himself: “My training, my thinking, my 
philosophy have all been directed toward the preservation of life—
that’s what I did, what I wanted to do.”324  As Dr. Chapman 
recognizes: 
Ambivalence is an equal pull in opposing directions . . . his desire is 
not a stranger to me.  I mean, I’ve thought that I might want to 
prescribe such pills to myself someday.  To relieve pain or to end my 
own life should the need arise. . . . I’ve thought of it often, but it’s 
always been slightly distanced.  A principled matter.  A theoretical 
option. But then the pain in his voice burst through, and I thought, . . . 
[i]f I would do it for myself, why not for him?325 
His concern raises an interesting ethical question about the privilege 
of a physician having access to take his own life, whereas Anthony is 
at the “mercy” of Dr Chapman. 
“He wants me to become his instrument,” Dr. Chapman thinks to 
himself, “[a] means for him . . . to enact his will?  . . .  Regarding my 
reservations—that uneasy murmuring just beyond the horizon of my 
thoughts—ignore that too. Governed only by his aims, I would be 
like the scalpel.”326  Later on, Anthony reminds him “[b]ut I am the 
one who is to die.”327  Dr. Chapman calmly explains: “So it’s all 
familiar and gentle. . . . No violence.  No death, even, really.  Just a 
321  See Richard Selzer, A Question of Mercy, N.Y. TIMES MAGAZINE, Sept. 22, 1991, at 32-33.  
322  See generally KLEINMAN, supra note 55; Daniel Callahan, Organized Obfuscation: Advocacy for 
Physician-Assisted Suicide, HASTINGS CENTER REP., Sept.-Oct. 2008 at 30-32; Sylvia A. Law, 
Physician-Assisted Death: An Essay on Constitutional Rights and Remedies, 55 MD. L. REV. 292 
(1996); Quill, supra note 55 , at 17; Rawls, supra note 55. 
323  HIPPOCRATES, supra note 35. 
324  RABE, supra note 320 , at 12.  
325  Id. at 14.  See also Randy A. Sansone & Lori A. Sansone, Physician Suicide: A Fleeting Moment 
of Despair, 6 PSYCHIATRY 18 (2009). 
326  RABE, supra note 320, at 24. 
327  Id. at 40. 
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pill and then sleep.  A trick and then sleep.  So it’s civilized.”328  But 
in fact, it wasn’t, as Anthony’s friend, Thomas, describes: 
I had to call the ambulance, didn’t I?  What else could I do?  . . . He was 
alive.  . . . They said he had to go into intensive care.  . . . They pumped 
out his stomach and washed out his stomach and put him on a 
respirator.  He is being fed intravenously.  They said they didn’t know 
if he was going to make it but they were going to try.  It was 
preposterous!329 
Theatre highlights the very real drama faced by many in society 
when cures, treatments, and palliative care are lacking. As a result, 
desperate requests for innovative ways to reduce suffering—
including the hastening of death through assisted suicide—challenge 
family, friends, and medical professionals, reminiscent almost a 
century earlier in Ghosts.330 
In contrast to the self-determined, orchestrated death witnessed 
in a Question of Mercy,331 Margaret Edson’s Wit332 provides vivid 
imagery of a patient’s lack of control when participating in a research 
study on advanced ovarian cancer.333  Edson’s play received much 
attention for its themes of empathy and dignity at the end of life by 
scholars in bioethics and medical humanities.334 In addition, the 
328  Id. at 54. 
329  Id. at 70. 
330  See IBSEN, supra notes 49-55 and accompanying text. These ethical and legal debates 
continue to play out in the legislature, the courts, the academic community, the media, and 
the public at large. See generally NEIL M. GORSUCH, THE FUTURE OF ASSISTED SUICIDE AND 
EUTHANASIA (2010); Yale Kamisar, Foreword: Can Glucksburg Survive Lawrence?: Another 
Look at the End of Life and Autonomy, 106 MICH. L. REV. 1453, 1453-54 (2008). 
331  See RABE, supra notes 320-29 and accompanying text. 
332  See EDSON, supra note 23. 
333  See Luca M. Bigatello et al., Ethical Considerations for Research in Critically Ill Patients, 31 
CRITICAL CARE MED. S178, S179 (2003); Ezekiel J. Emanuel et al., What Makes Clinical Research 
Ethical?, 283 JAMA 2701 (2000); W. Glannon, Phase I Oncology Trials: Why the Therapeutic 
Misconception Will Not Go Away, 32 J. MED. ETHICS 252 (2006). 
334  See, e.g., Linda A. Deloney & C. James Graham, Wit: Using Drama to Teach First-Year Medical 
Students About Empathy and Compassion, 15 TEACHING & LEARNING IN MED. 247 (2003); K.A. 
Lorenz et al., End-of-Life Education Using the Dramatic Arts: The Wit Educational Initiative, 79 
ACAD. MED. 481 (2004). 
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drama presents a rich source for examining the psychological and 
ethical implications of human experimentation.  Wit highlights the 
dangers of overzealousness with a research protocol that ultimately 
strips away any capacity to control one’s destiny, already ravaged by 
disease.  Vivian, a poetry professor, agrees to confront her terminal 
cancer full-force with Dr. Kelekian, the senior oncologist.  Although 
stoic, she is nevertheless a desperate research participant—akin to 
Ned in A Destiny of Me.335 
Kelekian explains rather matter of factly: “This treatment is the 
strongest thing we have to offer you.  And, as research, it will make a 
significant contribution to our knowledge.  . . . Here is the informed-
consent form.  . . . The important thing is for you to take the full dose 
of chemotherapy.”336  He then adds: “There may be times when you’ll 
wish for a lesser dose, due to the side effects.  But we’ve got to go 
full-force.  The experimental phase has got to have the maximum 
dose to be of any use.”337  Even though the informed consent process 
provides her information, and she had comprehension, the reality is 
that her voluntariness is limited by the parameters of the research 
protocol that she could not modify.338 
Later on in isolation, Vivian reflects: “My treatment imperils my 
health.  Herein lies the paradox.”339 Throughout the play, Wit 
dramatizes just how much Vivian gets manipulated as an object for 
more data and publications:340 
I have survived eight treatments of Hexamethophosphacil and 
Vinplatin at the full dose.  . . . I have broken the record.  . . . Kelekian 
and Jason are simply delighted.  I think they foresee celebrity status for 
themselves upon the appearance of the journal article.  . . . The article 
will not be about me, it will be about my ovaries.  It will be about my  
335  See KRAMER, supra notes 264-73 and accompanying text. 
336  EDSON, supra note 23, at 12. 
337  Id.  
338  See FADEN ET AL, supra note 82, at 255-57; Appelbaum et al., supra note 268. 
339  EDSON, supra note 23, at 43. 
340  See generally Marcia Angell, Publish or Perish: A Proposal, 104 ANNALS INTERNAL MED. 261 
(1986). 
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peritoneal cavity, which, despite their best intentions, is now crawling 
with cancer.341 
Another ethical concern Edson explores in Wit is Do Not 
Resuscitate (DNR) code orders—an issue for many at the end of 
life.342  Susie, the nurse, discusses resuscitation options with Vivian 
and Jason, the oncology fellow, and when they recognize the end is 
near, Susie reflects with Vivian: “They’ve learned a lot for their 
research.  . . . There just isn’t a good treatment for what you have yet. 
 . . . Well, they like to save lives.  So anything’s okay, as long as life 
continues.”343  Although the doctors believe, “[i]t doesn’t matter if 
you’re hooked up to a million machines,” it does to Susie and Vivian, 
who both reject any final heroics to save Vivian’s life.344  Jason, like 
his mentor Kelekian, does not want to give up on their research 
project: “I wish they could all get through it at full throttle.  Then we 
could really have some data.”345  And when Vivian takes her last 
breath, the ethical conflict between Susie and Jason escalates, 
highlighting the struggle between the patient’s autonomy at the end 
of life and the pressures a physician feels in relinquishing control, 
especially in research. As Jason initiates a full code, Susie screams at 
him, “She’s DNR!” and tries to grab him away.  Pushing her, he yells 
back with authority, “She’s Research!” But Susie shouts the last word, 
“She’s NO CODE!” as she throws him off Vivian’s bed.346 
In contrast to the end-of-life conflicts explored in Wit, Carl 
Djerassi’s 2000 play Immaculate Misconception347 imagines the tangled 
341  EDSON, supra note 23, at 43 (emphasis in original). 
342  See Zoë Fritz & Jonathan Fuld, Ethical Issues Surrounding Do Not Attempt Resuscitation 
Orders: Decisions, Discussions and Deleterious Effects, 36 J. MED. ETHICS 593, 593-95 (2010); 
Mitchell.T. Rabkin et al., Orders Not to Resuscitate, 295 NEW ENG. J. MED. 364, 365 (1976); 
Jacqueline K. Yuen et al., Hospital Do-Not-Resuscitate Orders: Why They Have Failed and How to 
Fix Them, 26 J. GEN. INTERNAL MED. 791, 791-92, 795 (2011). 
343  EDSON, supra note 23, at 53-54. 
344  Id., at 54-55,64-66.  
345  Id. at 59. 
346  Id. at 64.  
347  CARL DJERASSI, AN IMMACULATE MISCONCEPTION: SEX IN AGE OF MECHANICAL 
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web of intracytoplasmic sperm injection (ICSI)348 to bring forth new 
life through modern technologies.  Its creator Melanie Laidlaw and 
her collaborator, Felix Frankenthaler, consider the many ways in 
which new applications of this technology will be utilized, raising 
complex ethical challenges for our society over generations.  Melanie 
shares her excitement: “A few more months and I’m ready to try 
fertilizing a human egg by direct injection with a single sperm!”349  
Melanie notes that with her ICSI innovation, “women could draw on 
a bank account of their frozen young eggs and have a much better 
chance of having a normal pregnancy later on in life.  I’m not talking 
about surrogate eggs—”350 
Melanie continues to explain with enthusiasm: 
Each embryo will be screened genetically before the best one is 
transferred back into the woman’s uterus.  All we’ll be doing is 
improving the odds over Nature’s roll of the dice.  Before you know it 
the 21st century will be called ‘The Century of Art.  . . . The science 
of . . . A . . . R . . . T (Beat): assisted reproductive technologies.  Young 
men and women will open reproductive bank accounts full of frozen 
sperm and eggs.  And when they want a baby, they’ll go to the bank to 
check out what they need.351   
In recognition of the scope of Melanie’s innovation,352 Felix responds, 
“The Laidlaw Brave New World.”353  Is this an ethical practice that 
REPRODUCTION (Imperial College Press, 2000). 
348  See generally Practice Committee of the American Society for Reproductive Medicine & 
Practice Committee of the Society for Assisted Reproductive Technology, Genetic 
Considerations Related to Intracytoplasmic Sperm Injection (ICSI), 86 FERTILITY & STERILITY S103 
(2006); Maryse Bonduelle et al., Seven Years of Intracytoplasmic Sperm Injection and Follow-up of 
1987 Subsequent Children, 14 HUM. REPRODUCTION (SUPPLEMENT) 243, 243-45, 247 (1999); 
Mark D. Johnson, Genetic Risks of Intracytoplasmic Sperm Injection in the Treatment of Male 
Infertility: Recommendations for Genetic Counseling and Screening, 70 FERTILITY & STERILITY 397, 
397, 403-05 (1998); Richard J. Sherins et al., Intracytoplasmic Sperm Injection Facilitates 
Fertilization Even in the Most Severe Forms of Male Infertility: Pregnancy Outcome Correlates with 
Maternal Age and Number of Eggs Available, 64 FERTILITY & STERILITY 369, 369-73 (1995). 
349  DJERASSI, supra note 347, at 16 (underlined rather than italicized in text). 
350  Id. at 19 (underlined rather than italicized in text).  
351  Id. at 21 (underlined rather than italicized in text). 
352  See MARGARET S. MARSH & WANDA RONNER, THE EMPTY CRADLE: INFERTILITY IN AMERICA 
FROM COLONIAL TIMES TO THE PRESENT (The John Hopkins University Press, 1996). 
353  DJERASSI, supra note 347, at 22. 
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we want to promote or regulate?354  What implications will these new 
applications have for future generations and our conceptions of 
“normal” reproduction? 
The mammalian cloning of Dolly the sheep, born February 
1997,355 is another example of how genetic reproductive technology 
can push both the scientific and ethical envelope even further, 
capturing our public imagination.356  Reaching beyond Melanie’s 
“Brave New World,” in Caryl Churchill’s 2002 play A Number,357 the 
original son of Salter, Bernard 1 (B1), and his many clones, including 
Bernard 2 (B2), explore their origins, their identities, and their 
destinies.  Salter inquires if his sons want to know “how far has this 
thing gone, how many of these things are there,” to which B2 reacts, 
“you called them things.  I think we’ll find they’re people”; then 
Salter adds, “copies of you which some mad scientist . . .”358 
A Number vividly provides perspective on what it really means 
to be a unique human being beyond our genetic blueprint.359  When 
B2 queries, “if you’re not my father that’s fine. If you couldn’t have 
children or my mother, and you did in vitro . . . .”360  Salter confirms, 
“I am your father, it was by an artificial [sic] the forefront of science  
354  See DEBORA L. SPAR, THE BABY BUSINESS: HOW MONEY, SCIENCE, AND POLITICS DRIVE THE 
COMMERCE OF CONCEPTION 26-28 (Harvard Business School Press, 2006); T. Caulfield et al., 
Law and Policy in the Era of Reproductive Genetics, 30 J. MED. ETHICS 414 (2004); Kerry Lynn 
Macintosh, Brave New Eugenics: Regulating Assisted Reproductive Technologies in the Name of 
Better Babies, 2010 U. ILL. J.L. TECH. & POL'Y 257, 265-77, 292-307 (2010). 
355  Caught Napping by Clones, 385 NATURE 753, 753 (1997). 
356  See PRESIDENT’S COUNCIL ON BIOETHICS, Ethics of Cloning-to-Produce-Children, in HUMAN 
CLONING AND HUMAN DIGNITY: AN ETHICAL INQUIRY 83-116 (2002); Joyce C. Havstad, 
Human Reproductive Cloning: A Conflict of Liberties, 24 BIOETHICS 71, 71-74 (2010); Michael J. 
Sandel, The Ethical Implications of Human Cloning, 48 PERSP. IN BIOLOGY & MED. 241, 241-45 
(2005). 
357  CHURCHILL, supra note 24. 
358  Id. at 10-11. 
359  See Karen H. Rothenberg, “Being Human”: Cloning and the Challenges for Public Policy, 27 
HOFSTRA  L. REV. 639, 640 (1999). 
360  CHURCHILL, supra note 24, at 18. 
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but I am genetically” related to all the Bernards.361  Later on Salter 
acknowledges to B1: 
Nobody regrets more than me the completely unforeseen 
unforeseeable which isn’t my fault and does make it more upsetting 
but what I did . . . also it’s a tribute, I could have had a different one, a 
new child altogether . . . but I wanted you again because I thought you 
were the best.362 
But as B1 reminds us, “It wasn’t me again,” even with “the same 
raw materials,” and so the father justifies his actions “because they 
were perfect.”363  Although A Number is purely fictional, the play 
brings to life the ethical challenges at stake with technologies that 
may enable cloning humans—an idea that society has been unwilling 
to accept.364 
On the other hand, the public continues to embrace the drive for 
creating new innovations in medicine to address human disease.  The 
frenetic race to achieve novel scientific discoveries—in this case, the 
cure for cancer, is dramatized in Secret Order.365 Bob Clyman’s play 
highlights how the atmosphere of the scientific community both 
generates excitement for new ideas and the drive to claim success 
even when the data does not support it.366  As is typical in an 
academic medical center, there is a definite hierarchy—Dr. Robert 
Brock, the Director of a cancer institute, recruits a brilliant 
361  Id. at 19. 
362  Id. at 30-31. 
363  Id.  
364  See generally Timothy Caulfield, Human Cloning Laws, Human Dignity and the Poverty of the 
Policy Making Dialogue, 4 BMC MEDICAL ETHICS 3 (2003); Daniel Sperling, Bringing Life from 
Death: Is There a Good Justification for Posthumous Cloning?, J. CLINICAL RES. & BIOETHICS 
S1:001(Aug. 2011), available at http://www.omicsonline.org/2155-9627/2155-9627-S1-
001.pdf. 
365  BOB CLYMAN, SECRET ORDER (L.A. Theatre Works 2008). 
366  See Raymond L. Calabrese & Brian Roberts, Self-Interest and Scholarly Publication: The 
Dilemma of Researchers, Reviewers, and Editors, 18 INT’L J. EDUC. MGMT. 335 (2004); Raymond 
de Vries et al., Normal Misbehavior: Scientists Talk About the Ethics of Research, 1 J. EMPIRICAL 
RES. ON HUM. RES. ETHICS 43 (2006); John Maddox, Why the Pressure to Publish?, 333 NATURE 
493 (1988); James L. Mills, Data Torturing, 329 NEW ENG. J. MED. 1196 (1993).  
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immunologist, Dr. William Shumway who exclaims: “Everything 
we’ve tried . . .  surgery, chemo . . . comes at a terrible cost.  So it 
occurred to me . . . three years ago . . . you can’t imagine how difficult 
technically . . . and again it’s only one set of experiments, so this is 
completely premature, but I think I may have figured out how to 
cure cancer.”367  Brock can barely control his enthusiasm, “Do you 
understand the magnitude of what you’ve already done?  People 
have spent the last 20 years trying to figure out how tumor cells trick 
us into thinking they’re one of us.  You’re tricking tumor cells into 
thinking we’re one of them.  This is one of those moments . . . .”368  
“Say the word, and I’ll have you in CELL by the spring.  I know how 
to make things happen . . . .”369 
The presumption is that with innovative ideas and fortitude, 
Shumway’s research would change the fate of those with cancer. 
Unfortunately, the pressure to succeed blinds his moral compass—
with adverse implications to himself, his colleagues, cancer research, 
and public perceptions of scientific integrity.370  Shumway ultimately 
admits to Brock that his experiment has failed, much to their dismay: 
“I just assumed they were dying, but they aren’t . . . .”371  Brock is 
astounded: “Didn’t you realize . . . ?”372  Shumway responds 
defensively: 
Yes!  Every day . . . but it was also another day to fix the problem . . . 
and I knew I could, I just needed a little more time. . . .  I never lied or 
made up . . . these aren’t excuses . . . and then one day you said, 
‘Pfizer’ . . . .  All my results were in that envelope, but I couldn’t show 
you . . . not the way you were acting. . . .  Excited.373 
Brock snaps back, “I was excited, I thought I had a reason to 
be. . . .  Right, a few technical problems, nothing you couldn’t 
367  CLYMAN, supra note 365, at 1.  
368  Id. at 4. 
369  Id. at 5. 
370  See Brian C. Martinson et al., Scientists Behaving Badly, 435 NATURE 737 (2005); Patricia K. 
Woolf, Pressure to Publish and Fraud in Science, 104 ANNALS INTERNAL MED. 254 (1986). 
371  CLYMAN, supra note 365, at 66. 
372  Id.  
373  Id. at 66-67. 
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solve.”374 And Shumway quickly answers, “I never actually told you I 
solved them, and you never asked. . . . I knew publishing was a 
mistake.”  Brock clearly announces, “Realizing you had a serious  
problem, then sitting on it and ducking questions for the next six 
months. . . . Why the hell did you wait so long?”375 
In fact, the consequences of Shumway’s unethical behavior go far 
beyond publishing misleading data and the integrity of the scientific 
community to the fate of those with cancer.376  As Alice Curiton, 
Shumway’s student lab assistant points out, “Don’t you realize what 
you’ve done?!  If you had told people there was a problem, someone 
else might’ve solved it a month ago . . . and we’d be one month closer 
to a cure.  Did you ever think about how many people will die in that 
month?”377 
Cassandra Medley’s Relativity378 also explores how data can be 
manipulated to advance both scientific and political agendas.379  In 
this 2006 play, Claire, an African-American psychotherapist and 
educator, and her colleague-boyfriend, Malik, a sociologist, promote 
the theory that “people of color, or ‘melanated people’ possess 
greater quantities of life-enhancing properties of Melanin” to explain 
why they “excel athletically, culturally, intellectually, and 
spiritually.”380  Rejecting this theory, her daughter, Kalima, a Harvard 
graduate with a PhD in molecular genetics, is more interested in 
374  Id. at 66, 68. 
375  Id. at 68.  See also Public Health Service Policies on Research Misconduct, 70 Fed. Reg. 
28370, 28377-78 (May 17, 2005); Fiona Godlee et al., Editorial, Wakefield’s Article Linking 
MMR Vaccine and Autism Was Fraudulent, 342 BMJ  59, 64-66  (Jan. 2011); Douglas J. Opel et 
al., Assuring Research Integrity in the Wake of Wakefield, 342 BMJ 179, 179-180 (Jan. 2011). 
376  Brian Vastag, Cancer Fraud Case Stuns Research Community, Prompts Reflection on Peer Review 
Process, 98 J. NAT'L CANCER INST. 374, 374-75 (2006). 
377  CLYMAN, supra note 365, at 76. 
378  CASSANDRA MEDLEY, RELATIVITY (Broadway Play Publishing 2006). 
379  See Adele E. Clark et al., Biomedicalising Genetic Health, Diseases and Identities, in HANDBOOK 
OF GENETICS AND SOCIETY: MAPPING THE NEW GENOMIC ERA 21 (Paul Atkinson et al. eds., 
2009); Deborah A. Bolnick et al., Genetics: The Science and Business of Genetic Ancestry Testing, 
318 SCIENCE 399, 399-400 (2007); J. Kimmelman, The Post-Human Genome Project Mindset: 
Race, Reliability, and Health Care, 70 CLINICAL GENETICS 427, 430-31 (2006). 
380  MEDLEY, supra note 378, at 5. 
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exploring new and exciting genetic technologies. 381  Presumptions 
about the power of science and technological innovations to control 
destiny are influenced by the experiences of different generations 
with different perspectives.  From Claire’s point of view: 
This new technology is potentially a breakthrough for all humanity . . . 
but just where will this bold new technology take us?  Replicating 
organs . . . replicating people.  . . . If we do not stay on top of this new 
cloning technology, our bloodlines will continue to diminish, while the 
non-melanated will have found a way to preserve theirs.382 
As Malik reminds Kalima, “Your mom critiques the racist and 
ethical implications of this new cloning technology.  . . . And you’ll 
challenge these latest DNA findings.”383  In turn, Kalima defends her 
position, “what am I to challenge, exactly?  The human genome is the 
human genome.  . . . Their claim that race has no biological basis in 
fact.  Is so—confirmed.”384  She adds “how do ‘we’ deal with the facts 
that . . . the genomic sequencing proves that there’s more variation 
within groups, than between the groups we perceive to be different. 
 . . . The sequencing shows humans are all ninety-nine-point-nine 
percent genetically identical.” 385  To which Malik volleys back, 
“Right.  And the same so-called ‘data’ also ‘proves’ that humans 
share ninety-eight percent of their genes with the chimpanzee.  . . . 
Seems like that ‘two percent’ difference makes all the ‘difference.’”386  
In fact, as the Human Genome Project has evolved, so too has the 
scholarship on race and ethnicity in the context of genomic 
research.387 
381  Id. at 4. 
382  Id. at 4, 6.  
383  Id. at 14.  
384  Id.  
385  Id. at 15. 
386  Id.  (emphasis in original). 
387  See Troy Duster, Medicine. Race and Reification in Science, 307 SCIENCE 1050 (2005); Dorothy 
E. Roberts, Is Race-Based Medicine Good for Us?: African American Approaches to Race, 
Biomedicine, and Equality, 36 J.L. MED. & ETHICS 537 (2008). 
KAREN H. ROTHENBERG & LYNN W. BUSH 63
By 2003, the mapping of the human genome was complete and 
the scientific community was excited to create the technology that 
had the power to control our fate.388  Over fifty years before, Rosalind 
Franklin was painstakingly creating the images that would later 
contribute to the discovery of the double helix by Watson and 
Crick389—so well illuminated in Anna Ziegler’s 2009 play Photograph 
51.390  While Franklin thinks: “You know, I think one sees something 
new each time one looks at truly beautiful things.  . . . But they need 
to be so much clearer . . .  If we’re ever to find the structure.  . . . It’s 
going to get to the heart of everything. . . ,”391 Watson is thinking 
“more than ever—that the gene’s the thing.  I mean, we have to get to 
the bottom of it—discover how it replicates itself.  And so we need its 
structure.  . . . It’s just incredibly exciting.  . . . To be born at the right 
time.  There’s an element of fate to it, don’t you think? And I don’t 
believe in fate.”392 
In a twist of fate, just as the image became clearer to her that, 
“It’s a perfect X. It’s a helix,”393  Rosalind runs out of time, both 
because of her perfectionism, as noted by her colleagues, and her 
premature death from ovarian cancer.394  While Rosalind “realized 
the best thing is just to do one’s work and not worry so much about 
anything else.  It doesn’t matter anyway,” Watson bellows “But it 
does matter! It did matter. You can’t be in the race and ignore it at the 
same time!  That’s where she went wrong.”395  Shortly before she 
388  See Collins et al., supra note 300. 
389  See ANNE SAYRE, ROSALIND FRANKLIN AND DNA 24 (1st ed. 1975) (To this day there remains 
controversy about whether Watson and Crick sufficiently recognized Franklin’s 
contributions).   
390  ANNA ZIEGLER, PHOTOGRAPH 51 (2009) (Dramatists 2011). 
391  Id. at 21-22. 
392  Id. at 23. 
393  Id. at 35.  See A. Klug, Rosalind Franklin and the Discovery of the Structure of DNA, 219 NATURE 
808, 808 (1968). 
394  See Klug, supra note 393,   at 808. 
395  ZIEGLER, supra note 390, at 37. See generally BRENDA MADDOX, ROSALIND FRANKLIN: THE 
DARK LADY OF DNA 319 (1st ed. 2002). 
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dies, Rosalind reflects: “The work is never finished and in the 
meantime our bodies wind down, tick slower, sputter out.”  While 
her colleague, Wilkins, notes in the end: “But we lost,” Rosalind, 
being a true researcher to the end, answers back with more questions, 
“Lost?  No . . . We all won. The world won, didn’t it?”396 
Another theatrical production that reflects back in time and 
personalizes the challenge of controlling one’s fate in the light of 
incurable cancer is Freud’s Last Session.397  Mark St. Germain’s play 
dramatizes a fictionalized conversation in 1939 between the frail and 
elderly Dr. Sigmund Freud and young C.S. Lewis, a lay theologian 
and literary critic, exploring their different perspectives on the 
meaning of life.398  Frustrated by the inability of the medical 
profession to change the course of his disease and create innovations 
to alleviate his pain and suffering, Freud morally justifies his decision 
to control his ultimate fate with assisted suicide.399 
Freud reveals to Lewis: “My mood these days is ruled by my 
body.  . . . It’s the prosthesis.  It doesn’t fit properly; it chafes my 
mouth.  Anna calls it ‘The Monster.’  I must clean it and call her to 
readjust it.  . . . No one but Anna touches it.  . . . Especially not the 
doctors.  Thirty operations and I should have learned from the 
first.”400  “It’s nearly eaten through my cheek.  It is inoperable.  It’s 
only a matter of time . . . for me to decide.  Dr. Schur and I have a 
pact.  He promised me at the beginning he won’t desert me at the 
end.”401  Startled, Lewis asks, “Are you saying you’ll commit 
suicide?”  And Freud quickly replies, “I’m saying I will kill myself 
before the cancer does.  Don’t look at me that way.  You don’t need to 
say it: Suicide is wrong and a sin!  . . . look into my mouth and you 
396  ZIEGLER, supra note 390, at 57 (alteration in original). 
397  MARK ST. GERMAIN, FREUD’S LAST SESSION (Dramatists 2010). 
398  Id. 
399  Id. at 27. See KLEINMAN, supra note 55; Pierre Gagné et al., Psychopathology and Suicide among 
Quebec Physicians: A Nested Case Control Study, 2011 DEPRESSION RES. & TREATMENT 936327 at 
*3 (2011); Quill, supra note 55, at 17.
400  ST. GERMAIN, supra note 397, at 23. 
401  Id. at 27. 
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will see hell has arrived already.”402  As a physician, Freud has access 
to the knowledge and the means to carry out his plan for terminating 
his own life—just like Dr. Chapman voiced in A Question of Mercy.403 
Moisés Kaufman’s 33 Variations404 juxtaposes characters of the 
past, including Beethoven, with the present to explore the limits of 
innovation when confronted with the neurodegenerative disease 
amyotrophic lateral sclerosis (ALS),405 for which science has yet to 
offer hope for a cure or dignified death.406  This play revolves around 
Katherine, a musicologist who has been diagnosed with ALS; Clara, 
her daughter; and Gertie, a friend and professional colleague whose 
aunt had died of ALS.  Although technology provides for an 
augmentative speech device to assist Katherine in communicating 
with others, as the disease progresses it is clear that she is losing 
control of her body and thus is determined to seize control of her 
final destiny, as explored in so many earlier plays from Ghosts to 
Freud’s Last Session. 
Katherine declares: “I want to live,” yet clarifies, “But only while 
I can still communicate.  If I cannot make myself understood, I want 
to be given morphine and left to die.  I want that to be clear.” 407  
When Clara questions: “And who will be administering the 
morphine?,”  Katherine’s plan is clear: “Gertie has agreed to do it.”408  
And when Clara expresses with concern: “What happens if after you 
can’t communicate you change your mind and you want to go on 
living?,” Katherine quickly lets her know: “That won’t happen.”409  
402  Id.  
403  RABE, supra note 320, at 14. 
404  KAUFMAN, supra note 25. 
405  See generally John T. Dimos et al., Induced Pluripotent Stem Cells Generated from Patients with 
ALS Can Be Differentiated into Motor Neurons, 321 SCIENCE 1218 (2008). 
406  See Harold D. Foster & Abram Hoffer, The Two Faces of L-Dopa: Benefits and Adverse Side 
Effects in the Treatment of Encephalitis Lethargica, Parkinson’s Disease, Multiple Sclerosis and 
Amyotrophic Lateral Sclerosis, 62 MED. HYPOTHESES 177, 181 (2004); David J. Oliver & Martin 
R. Turner, Some Difficult Decisions in ALS/MND, 11 AMYOTROPHIC LATERAL SCLEROSIS 339, 
339 (2010). 
407  KAUFMAN, supra note 25, at 85. 
408  Id. 
409  Id. 
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But in fact, it sometimes does.  Patients are often left in a neurological 
state where it is not always possible to determine their wishes—a 
difficult ethical dilemma intensified by cutting-edge technology.410 
Following Katherine’s death, Clara reads, at her mother’s 
request, her final lecture that ends with a quote from Beethoven, the 
composer who had slowly become deaf in adulthood and had 
inspired much of Katherine’s scholarship and philosophy on life: 
BEETHOVEN:   Let us begin with the primary cause of things. 
    Let us begin with how something came about. 
    Why it came about in that particular way 
    and became what it is.411 
ACT VI: GENOMES & UNKNOWNS 
Over the last decade, particularly in the context of the genomics 
revolution, expectations have increased to better understand the 
causes of disease and disorders, as well as the promise of innovative 
treatments—echoed by Kaufman’s Beethoven in the context of his 
world three centuries ago.  Lucy,412 the 2009 play by Damien Atkins, 
examines the frustrations of Vivian, an anthropologist, as she tries to 
discover the origins of her daughter Lucy’s “autistic” behavior with 
Morris, Lucy’s therapist: “I’ve been looking at autism triggers . . . 
there’s a lot of conflicting information.”413  When Morris notes that 
“it’s an evolving study,” Vivian adds: “But most scientists agree that 
there has to be a genetic component. . . . they’ve been able to isolate a 
couple of potential autism genes . . . .”414  Morris adds, “But there 
may be as many as a hundred involved, we don’t know. . . . there are  
410  See Joseph J. Fins & Nicholas D. Schiff, Neuroimaging & Disorders of Consciousness: Clinical 
and Ethical Challenges for Research and Practice, in NEUROETHICS IN PRACTICE (Anjan Chatterjee 
and Martha J. Farah et al. eds., forthcoming 2012); THE OXFORD HANDBOOK OF NEUROETHICS, 
supra note 222, at 343-494; Ruth Macklin, Bioethics, Vulnerability, and Protection, 17 BIOETHICS 
472 (2003). 
411  KAUFMAN, supra note 25, at 103. 
412  ATKINS, supra note 26, at 55. 
413  Id. 
414  Id. at 55 
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lots of people trying to figure out where it came from.  I’m just trying 
to figure out how to fix it now that it’s here.”415 
The back and forth dialogue between Vivian and Morris 
illustrates the continuing controversy on how to treat a complex 
disorder in the midst of not truly understanding the interactions 
between genetic and environmental factors.416  Moreover, even if we 
have a clear sense of the scientific basis for the cause of Autism 
Spectrum Disorder, challenges would remain, particularly given the 
variability of expression and permutations in functioning.417  Typical 
of how parents feel with this level of uncertainty, Vivian is puzzled: 
“You want to fix it, but you don’t even know what it is yet.”418 When 
Morris responds defensively, “That’s not true, it’s just, it’s 
complicated.  . . . [T]here are a lot of theories out there and not enough 
proof,” Vivian continues, “I’m confused—you keep telling me that 
you know what you’re doing. . . . that you’re on the cutting edge. . . . 
why don’t tell me something you do know!”419 
Although the scientific landscape changes over time, we are still 
faced with the reality of the limits of our knowledge.420  Contentious 
415  Id. at 55, 57. 
416  See generally Fiona Godlee et al., Editorial, Wakefield’s Article Linking MMR Vaccine and 
Autism Was Fraudulent, 342 BRIT. MED. J. c7452, 64 (2011); Anna Kirkland, The Legitimacy of 
Vaccine Critics: What is Left After the Autism Hypothesis, 37 J. HEALTH POL. POL'Y & L. 69 
(2012); A.J. Russo & Robert deVito, Analysis of Copper and Zinc Plasma Concentration and the 
Efficacy of Zinc Therapy in Individuals with Asperger's Syndrome, Pervasive Developmental 
Disorder Not Otherwise Specified (PDD-NOS) and Autism, 6 BIOMARKER INSIGHTS 127 (2011).  
417  See Daniel B. Campbell et al., Association of Oxytocin Receptor (Oxtr) Gene Variants with 
Multiple Phenotype Domains of Autism Spectrum Disorder, 3 J. NEURODEVELOPMENTAL 
DISORDERS 101 (2011); An Crepel et al., Narrowing the Critical Deletion Region for Autism 
Spectrum Disorders on 16p11.2, 156 AM. J. MED. GENETICS PART B, NEUROPSYCHIATRIC 
GENETICS 243 (2011); Guy Horev et al., Dosage-Dependent Phenotypes in Models of 16p11.2 
Lesions Found in Autism, 108 PROC. NAT’L ACAD. SCI. U.S.A. 17076 (2011); Veronica J. Vieland 
et al., Novel Method for Combined Linkage and Genome-Wide Association Analysis Finds Evidence 
of Distinct Genetic Architecture for Two Subtypes of Autism, 3 J. NEURODEVELOPMENTAL 
DISORDERS 113 (2011). 
418  ATKINS, supra note 26, at 57 (emphasis in original).  
419  Id. at 57-58 (emphasis in original). 
420  See Gary E. Marchant & Jason S. Robert, Genetic Testing for Autism Predisposition: Ethical, 
Legal and Social Challenges, 9 HOUS. J. HEALTH L. & POL’Y 203 (2009); Matthew W. State & Pat 
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debate continues on how to categorize the wide spectrum of 
behavioral and neurological manifestations that have societal and 
financial implications for medical and education benefits421 while 
trying to minimize stigmatizing labels.422  Theatre vividly captures 
the dramatic implications of familial struggles to search for causal 
explanations and effective treatments423 to control the fate of 
individuals with neuropsychiatric disorders. 
Lisa Loomer’s Distracted424 further explores these themes through 
Mama, the central character, and her husband Dad, who question the 
role of heredity and environment in explaining their son’s diagnosis 
as Attention Deficit Hyperactivity Disorder and the treatment 
alternatives425 to make him act like a “normal” child. On a more 
fundamental level, they wonder whether his behavior is a function of 
our distracted society rather than a medical disorder.426  Through a 
series of dialogues with each other, and with a revolving door of 
doctors, they discover the risks of and limitations with current  
Levitt, The Conundrums of Understanding Genetic Risks for Autism Spectrum Disorders, 14 
NATURE NEUROSCIENCE 1499 (2011). 
421  See Sheryl Dicker & Emily Bennett, Engulfed by the Spectrum: The Impact of Autism Spectrum 
Disorders on Law and Policy, 45 VAL. U. L. REV. 415 (2011). 
422  See Marja-Leena Mattila et al., Autism Spectrum Disorders According to DSM-IV-TR and 
Comparison with DSM-5 Draft Criteria: An Epidemiological Study, 50 J. AM. ACAD. CHILD & 
ADOLESCENT PSYCHIATRY 583 (2011); James L, Sanders, Qualitative or Quantitative Differences 
Between Asperger’s Disorder and Autism? Historical Considerations, 39 J. AUTISM & 
DEVELOPMENTAL DISORDERS 1560 (2009); Sami Timimi, Autism Is Not a Scientifically Valid or 
Clinically Useful Diagnosis, 343 BMJ d5105 (2011); Lorna Wing et al., Autism Spectrum 
Disorders in the DSM-V: Better or Worse than the DSM-IV?, 32 RES. DEVELOPMENTAL 
DISABILITIES 768 (2011). 
423  See Allison E. Golnik & Marjorie Ireland, Complementary Alternative Medicine for Children 
with Autism: A Physician Survey, 39 J. AUTISM & DEVELOPMENTAL DISORDERS 996 (2009); 
Susan E. Levy & Susan L. Hyman, Complementary and Alternative Medicine Treatments for 
Children with Autism Spectrum Disorders, 17 CHILD & ADOLESCENT PSYCHIATRIC CLINICS OF N. 
AM. 803 (2008). 
424  Loomer, supra note 27. 
425  Id. at 25; see also Eran Ben-Arye et al., Attitudes Toward Integration of Complementary and 
Alternative Medicine in Primary Care: Perspectives of Patients, Physicians and Complementary 
Practitioners, 70 PATIENT EDUC. & COUNSELING 395 (2008); Kathi J. Kemper et al., American 
Academy of Pediatrics: The Use of Complementary and Alternative Medicine in Pediatrics, 122 
PEDIATRICS 1374 (2008). 
426  LOOMER, supra note 27, at 50.  
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approaches for explaining and controlling this disorder—just like 
Autism Spectrum Disorder in Lucy.427 
When Mama goes to Dr. Waller looking for answers, this 
neuropsychologist opines: “Studies indicate the best course of 
treatment is a combination of behavior modification and 
medication.”428  Mama then consults with Dr. Zavala and is glad 
when this child psychologist confirms that “you’re right to try 
everything else first, every conceivable good option,” and Mama 
asks, “[L]ike neurofeedback? Orthomolecular therapy? Herbs?  . . . 
Would Ritalin . . . get him out of his pajamas?”429  However, Dad is 
not happy after Dr. Zavala says, “When Ritalin works, it can seem 
like a miracle,” and declares: “No way am I putting my kid on 
Ritalin!”430  But Mama keeps on asking: “Would Ritalin be a better 
mother than I am? . . . if it’s a real disease—like diabetes—then 
shouldn’t one thing work.  Like insulin.”431  This dialogue so well 
captures the frustrating reality that a “quick fix” does not always 
work given the wide variability with many neuropsychiatric 
disorders. 
And so the parents keep searching for an innovation to modify 
their son’s fate.  Whereas the next psychiatrist, Dr. Jinks, explains: 
“The brain is highly complex. . . .  ADD is a neurological condition. . . 
a hereditary condition,”432 Dad questions yet another, Dr. Karnes, to 
“explain the BioMeridian machine that you use to diagnose the food 
and environmental allergies you say my son has?”433  And Dr. Karnes 
admits, “The truth is, I don’t fully understand how it works myself, I 
427 Id. See Atkins, supra notes 26, 412-23 and accompanying text.  See also Ginger Polich et al., 
The Need to Act a Little More 'Scientific': Biomedical Researchers Investigating Complementary and 
Alternative Medicine, 32 SOC. HEALTH & ILLNESS 106 (2010). 
428  LOOMER, supra note 27, at 31. 
429  Id. at 41, 45. 
430  Id. at 45. 
431  Id. at 45, 48. 
432  Id. at 48 (emphasis in original); the diagnosis of ADD, Attention Deficit Disorder, is now 
referenced as ADHD, Attention Deficit Hyperactivity Disorder. 
433  Id. at 60 
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just know from my own clinical experience in addition to reports 
from Europe that it does.  . . . Imbalances in various organs are 
believed to—.”434  Like so many of the earlier plays, Distracted 
captures the ethical challenge of reaching the appropriate balance 
between encouraging the creation of innovation and protecting the 
public from ineffective interventions.435 
In the same year, Brian Yorkey’s Pulitzer Prize-winning musical 
Next to Normal436 depicts the desperate search for medical innovations 
to control Diana’s severe psychiatric disorder—depression with 
delusional episodes and a history of sixteen-years of medication.437  
The show revolves around Diana, her family, and her many doctors 
struggling to find an effective treatment regimen and the implications 
of these exhausting attempts to get her to function at least “next to 
normal.”438  Through a series of powerful musical numbers and 
dialogue, Diana and the psychiatrists explore how the evolving list of 
different medical interventions from psychopharmacology to  
434  Id. 
435  See Pediatric Research Equity Act of 2007, 21 U.S.C. § 355c (2006) (mandating pediatric 
studies of some drugs under the authority of the FDA); Ruth L. Fischbach & Gerald D. 
Fischbach, Neuroethicists Needed Now More Than Ever, 8 AM. J. BIOETHICS 47 (2008); Aaron 
Levin, Did FDA's Limited DBS Approval Create New Set of Problems?, PSYCHIATRIC NEWS, Mar. 
18, 2011, at 6; Press Release, U.S. Food & Drug Admin., FDA Directs ADHD Drug 
Manufacturers to Notify Patients about Cardiovascular Adverse Events and Psychiatric 
Adverse Events (Feb. 21, 2007), http://www.fda.gov/NewsEvents/Newsroom/ 
 PressAnnouncements/2007/ucm108849.htm; Press Release, U.S. Food & Drug Admin., 
FDA Launches a Multi-Pronged Strategy to Strengthen Safeguards for Children Treated 
with Antidepressant Medications (Oct. 15, 2004), http://www.fda.gov/NewsEvents/ 
 Newsroom/PressAnnouncements/2004ucm108363.htm.  
436  BRIAN YORKEY, NEXT TO NORMAL (2009) (Theatre Communications Group 2010). 
437  Id; see also Shadi Beshai et al., Relapse and Recurrence Prevention in Depression: Current 
Research and Future Prospects, 31 CLINICAL PSYCHOL. REV. 1349 (2011); Timothy I. Mueller et 
al., Recurrence After Recovery from Major Depressive Disorder During 15 Years of Observational 
Follow-Up, 156 AM. J. PSYCHIATRY 1000 (1999); Richard C. Shelton & Madhukar H. Trivedi, 
Challenges and Algorithm-Guided Treatment in Major Depressive Disorder, 72 J. CLINICAL 
PSYCHIATRY e14 (2011). 
438  See YORKEY, supra note 436; see also Paul S. Appelbaum et al., Therapeutic Misconception in 
Clinical Research: Frequency and Risk Factors, IRB: ETHICS AND HUM. RES., Mar.-Apr. 2004, at 1. 
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hypnosis to electro convulsive therapy (ECT) may control her fate—
and theirs—for better or for worse.439 
After Doctor Fine sings, “The round blue ones with food but not 
with the oblong white ones. The white ones with the round yellow 
ones but not with the trapezoidal green ones. Split the green ones 
into thirds with a tiny chisel,” Diana describes her reality: “I’ve got 
less anxiety, but I have headaches, blurry vision, and I can’t feel my 
toes.”440  “So we’ll try again, and eventually we’ll get it right,” Doctor 
Fine responds, trying to reassure her—and himself.441  To which 
Diana observed: “Not a very exact science, is it?”442 
Some time later, another psychiatrist, Doctor Madden, 
recommends ECT therapy,443 calmly offering that “the electricity 
involved is barely enough to light a hundred-watt bulb,” minimizing 
the frightening concept of being shocked.444 Diana reflects on her 
experience with the latest treatment in song: 
In an instant, lightning flashes
And the burst might leave me blind— 
When the bolt of lightning crashes  
And it burns right through my mind. 
It’s like someone drained my brain out, 
Set my frozen mind to thaw.  
Let the lethargy and pain out  
While I stood and watched, in awe. 
439  See YORKEY, supra note 436; see also John A. Cohan, Psychiatric Ethics and Emerging Issues of 
Psychopharmacology in the Treatment of Depression, 20 J. CONTEMP. HEALTH L. & POL’Y 115 
(2003). 
440  YORKEY, supra note 436, at 17-18. 
441  Id. at 18 
442  Id.  
443  See generally THE ECT HANDBOOK: THE THIRD REPORT OF THE ROYAL COLLEGE OF 
PSYCHIATRISTS’ SPECIAL COMMITTEE ON ECT 12 (Allan I.F. Scott ed., Bell & Bain Limited 2d 
ed. 2005); Matthew V. Rudorfer et al., Electroconvulsive Therapy, in PSYCHIATRY 1865-901 
(Allan Tasman et al. eds., 2d ed. 2003). 
444  YORKEY, supra note 436, at 53. 
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I am riding on the brightest buzz. . .  
I am worlds away from who I was. . .  
And they told me it would change me— 
Though they don’t know how it does.445 
Once again, a character dramatizes both the promises and perils of 
medical interventions, and the uncertainties of their futures. 
The motivation to use medical innovations to control the fate of 
future generations has been accelerated by the promise of emerging 
reproductive and genetic technologies.446  Dorothy Fortenberry’s The 
Good Egg447 examines how a fictionalized pre-implantation genetic 
diagnosis of Bipolar Disorder has the potential to prevent its heritable 
transmission.448  The tension set up in this 2010 play revolves around 
Meg, who wants to become pregnant through assisted reproductive 
technology, and her brother, who is diagnosed as Bipolar, just like 
their dad who committed suicide. 
When Meg tries to justify: “it’s done all the time . . . to make sure 
the baby’s healthy and normal and—” Matt quickly interrupts, “Not 
bipolar.”449  He further adds: “You said they were checking for 
diseases.” Meg confirms, “For Huntington’s and Parkinson’s and 
Alzheimer’s and MS and—.”  “Me?” Matt shouts.  Meg goes on to 
explain: “It’s a new test. They just located the genes recently, and—.”  
Interrupting again, Matt declares: “You’re taking advantage of the 
technology.  Like ‘New! Improved! Now with no bipolar!’”  Trying to  
445  Id. at 60. 
446  See generally R. Alta Charo & Karen H. Rothenberg, The Good Mother: The Limits of 
Reproductive Responsibility and Genetic Choice, in WOMEN & PRENATAL TESTING: FACING THE 
CHALLENGES OF GENETIC TECHNOLOGY 105 (Karen Rothenberg & Elizabeth Thomson eds., 
1994). 
447  FORTENBERRY, supra note 28. 
448  Assisted reproductive technologies have evolved primarily in the private sector, largely 
because there has been little federal funding in this controversial area. Note, Guiding 
Regulatory Reform in Reproduction and Genetics, 120 HARV. L. REV. 574, 548-79 (2006).  
Historically, it is professional organizations that have established medical and ethical 
guidelines, rather than government regulations, for these emerging technologies. See Naomi 
R. Cahn & Jennifer M. Collins, Eight is Enough, 103 NW. U. L. REV. COLLOQUY 501, 507-08 
(2009). 
449  FORTENBERRY, supra note 28, at 14. 
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calm Matt down, Meg lets him know: “It is a totally routine, common 
thing to do, just to be on the safe side.”450 
The dialogue highlights how advances in assisted reproductive 
technology generate new opportunities for Meg to be able to use 
innovative genetic tests451 prior to implantation452 to select what type 
of child she would be willing to parent, reminiscent of Immaculate 
Misconception.453  The synergy between the utilization of these 
cutting-edge technologies and the value-laden choices these 
innovations create, raise complex ethical dilemmas for individuals, 
families and society that center on the fundamental question of 
whether there should be limits on how these technologies are used to 
change the fate of others.454 
Wanting his sister to reconsider her pursuit of genetic testing, 
Matt tries to make Meg feel guilty and adds: “Mom would never 
have.”455  Meg snaps back: “You don’t know what Mom would have 
said about it, they hadn’t even invented genetic testing.”456  Matt is 
unrelenting: “Mom just had a kid like normal people have kids,” and 
Meg reminded him: “We don’t live in that world anymore.”457  In an 
emotional turmoil, Matt declares: “You are genetically editing me 
from the code of who we are.  You’re eliminating me and you’re 
450  Id. . 
451  See Tiffany A. Greenwood et al., Further Evidence for Linkage of Bipolar Disorder to 
Chromosomes 6 and 17 in a New Independent Pedigree Series, 14 BIPOLAR DISORDERS 71, 72, 75 
(2012); Radhika Kandaswamy et al., Tests of Linkage and Allelic Association between Markers in 
the 1p36 Prkcz (Protein Kinase C Zeta) Gene Region and Bipolar Affective Disorder, 159 AM. J. 
MED. GENETICS. PART B, NEUROPSYCHIATRIC GENETICS 201 (2012). 
452  See Robert Klitzman et al., Preimplantation Genetic Diagnosis on in Vitro Fertilization Clinic 
Websites: Presentations of Risks, Benefits and Other Information, 92 FERTILITY & STERILITY 1276 
(2009). 
453  See Djerassi, supra notes 347-54 and accompanying text.  See also Andrew B. Coan, Is There a 
Constitutional Right to Select the Genes of One’s Offspring?, 63 HASTINGS L.J. 233, 234-235 
(2011). 
454  See ANNE KERR & TOM SHAKESPEARE, GENETIC POLITICS: FROM EUGENICS TO GENOME (2002). 
455  FORTENBERRY, supra note 28, at 29. 
456  Id. 
457  Id. at 30. 
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eliminating Dad.”458  As the play concludes, Meg reflects: “I thought 
about it, calling up to cancel . . . but I couldn’t do it.  I couldn’t handle 
the thought, the guilt of saying to a child ‘I could have prevented 
your feeling this way, but I chose not to.’”459  This technological 
imperative of “reproductive accountability”460 and her personal 
experiences are just too powerful for Meg to resist. 
Because values among individuals are so diverse and fluid, the 
powerful role of relationships within a family varies across a 
continuum from gently guiding, to denouncing a woman’s choice, to 
the threat of severing all ties, as we witnessed in Twilight of the 
Golds.461  Different judgments about “what is normal?” are shaped by 
our experiences and cultural expectations, which directly impact on 
how we frame our identities and those of others within the context of 
families and society—a message that has evolved from the disabilities 
community.462  In turn, these perceptions color our presumptions 
about the power of science and technology to control destiny. 
Despite Matt’s strong feelings, Meg is adamant in her beliefs that the 
use of innovative technologies would provide the path to a better 
place. 
As we have witnessed in so many plays, the challenges posed by 
chronic neuropsychiatric and neurological disorders motivate the 
quest to discover and experiment with all modes of medical 
interventions.463  In the last play explored, Sharr White’s 2011 
458  Id. at 51. 
459  Id. at 53-54. 
460  See generally Charo & Rothenberg, supra note 446. 
461   See TOLINS, supra notes 22, 302-08 and accompanying text. 
462  See Adrienne Asch et al., Respecting Persons with Disabilities and Preventing Disability: Is There 
Conflict?, in THE HUMAN RIGHTS OF PERSONS WITH INTELLECTUAL DISABILITIES: DIFFERENT BUT 
EQUAL 319 (Stanley S. Herr et al. eds., 2011); PRENATAL TESTING AND DISABILITY RIGHTS (Erik 
Parens & Adrienne Asch eds., 2000); JEROME EDMUND BICKENBACH, ETHICS, LAW, AND 
POLICY (2012); DAVID T. WASSERMAN ET AL., QUALITY OF LIFE AND HUMAN DIFFERENCE : 
GENETIC TESTING, HEALTH CARE, AND DISABILITY (2005). 
463  See HARVEY, supra note 14; ONE FLEW OVER THE CUCKOO’S NEST, supra note 151; EQUUS, 
supra note 180; AGNES OF GOD, supra note 18; KIND OF ALASKA, supra note 223; LUCY, supra 
note 26, DISTRACTED, supra note 27; NEXT TO NORMAL, supra note 436. 
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production The Other Place464 brings to life many of the themes and 
images dramatizing attempts to manipulate fate through medical 
science.  The main character, Julianna, is a brilliant scientist who has 
devoted her professional life to finding a cure for Alzheimer’s 
disease.465  While presenting at an academic meeting, she suddenly 
loses her memory and stops talking—thinking that she has had a 
stroke or possibly brain cancer.  As fate would have it, imaging 
technology confirms that it was neither of these, but rather she is 
afflicted with the very disease that was her scientific specialty.466 
With her husband Ian and nurse Bobby, Julianna finds the 
support to participate in experimental treatment.  One can only 
wonder, when reflecting on the principle of social justice, whether 
this access to experimental treatment would have been as readily 
available to patients not connected to the scientific community.467  
Juliana reports: “had my first injection, been given my pill . . .  and 
suddenly I feel . . . I don’t know. I can’t explain it.”  She rejoices, “It 
can’t be true, I’m just being hopeful.  . . . Well I just feel this morning 
as if . . . I’m . . . as if a . . . something.  That was in front my eyes. Has 
been lifted . . . this is why you use a, a, whatever—. “468  Bobby 
helped her find her words, “Test group? Placebo . . . ?”469  As a 
scientist, Juliana clearly recognizes the power of a placebo,470 and 
acknowledges, “Yes; we just want so badly to think we feel better.”471 
464  WHITE, supra note 5.  
465  See Paul Hollingworth et al., Common Variants at Abca7, Ms4a6a/Ms4a4e, Epha1, Cd33 and 
Cd2ap Are Associated with Alzheimer’s Disease, 43 NATURE GENETICS 429 (2011); Adam C. Naj 
et al., Common Variants at Ms4a4/Ms4a6e, Cd2ap, Cd33 and Epha1 Are Associated with Late-
Onset Alzheimer’s Disease, 43 NATURE GENETICS 436 (2011); Nidhi Subbaraman, Alzheimer’s 
Genetic Map, 29 NATURE BIOTECHNOLOGY 179 (2011). 
466  See Li Liu et al., Trans-Synaptic Spread of Tau Pathology in Vivo, 7 PLOS ONE e31302 (2012). 
467  See Jeffrey L. Cummings, Alzheimer’s Disease Clinical Trials: Changing the Paradigm, 13 
CURRENT PSYCHIATRY REP. 437 (2011); THE OXFORD HANDBOOK OF NEUROETHICS, supra note 
222, at 516 (discussing fair subject selection). 
468  WHITE, supra note 5, at 41-42. 
469  Id. at 42. 
470  See generally Michael Specter, Annals of Science: The Power of Nothing, NEW YORKER, Dec. 12, 
2011, at 30. 
471  WHITE, supra note 5, at 42. 
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As the play ends, Julianna expresses her hopes that the 
experimental drug will diminish the progression of her disease, while 
still recognizing its limitations: 
A new version of Identamyl is, we’re certain, hard at work.  Though 
neuron death is still occurring, our hope, however, is that it is slowing, 
or even coming to a halt.  Regardless of treatment, the memories I had 
will never be restored.  Neither will my very sense of self.  . . . Not 
being myself is, oddly, who I am.  Very rarely, triggered by who 
knows what, visions—ghosts really—of my past life do appear quite 
vividly.  . . . I’m also taking a new drug meant to help clear these 
plaques, but because it’s made by a competitor, if you ask me what it 
is . . . I’ll tell you I don’t remember.  . . . There are many conversations I 
do not retain.  . . . I am a woman in-between: The sky and the earth. 
The past and the future.  This place . . . and the other.472 
Because of her firm belief in the miracle of science, she holds on 
to the presumption that innovations in medicine still have the power 
to enable her to control her fate by leading her away from “the other 
place.” 
EPILOGUE 
This selection of theatrical narratives represents but a small 
sample of possibilities to spark the “moral imagination”473 and 
facilitate interdisciplinary discourse on the ethical, legal, and social 
implications of transformative medical technologies over time.  These 
plays provide a unique creative and analytical stage for imagining 
our bioethical past and future and our attempts to control our fate 
through innovations in medicine.  At the same time, they also raise 
our sensitivity toward human conflicts ‘‘just because it is not our life, 
places us in a moral position that is favorable for perception and it 
shows us what it would be like to take up that position in life.”474  By 
472  Id. at 42-43 (emphasis in original). 
473  See R.S. DOWNIE & J. MACNAUGHTON, BIOETHICS AND THE HUMANITIES: ATTITUDES AND 
PERCEPTIONS 134 (2007). 
474  MARTHA C. NUSSBAUM, LOVE’S KNOWLEDGE: ESSAYS ON PHILOSOPHY AND LITERATURE 162 
(1990). 
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fostering an emotional engagement with the actors (or by portraying 
a character) we can gain an appreciation for, and recognition of, how 
advancements in technology shape both translational clinical practice 
and its ensuing ethical challenges—especially on human 
relationships. 
While the complexity of medical innovations has evolved over 
time, the human response towards attempts to modify our destiny 
has remained relatively consistent—as witnessed in classic and 
contemporary theatre through the lens of history.  This historical 
perspective provides the broader contextual script, while theatre 
allows us to effectively experience and imagine the actors through a 
more personal lens—potentially facilitating insight and expanding 
our understanding of ethical and societal implications through the 
lives of others.  As the poet Percy Bysshe Shelley, spouse of the 
original Frankenstein creator Mary Shelley, observed: 
[History is the] cyclic poem written by Time upon the memories of men. The 
past, like an inspired rhapsodist, fills the theatre of everlasting generations 
with [her] harmony.475 
475  Augustine Birrell, The Muse of History, in OBITER DICTA: SECOND SERIES 184 (1887) (quoting 
PERCY BYSSE SHELLEY, IN DEFENCE OF POETRY (1821) (alteration in original)).  
